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Antibiotic resistance is a global health concern, addressed by the World Health Organization, 
the CDC, EFSA and the United States White House. This issue is primarily a consequence of 
the overuse and misuse of antibiotic agents in both human and veterinary medicine. However, 
as of 2016, information regarding the presence of antibiotic resistant bacteria in different 
environments in South Africa is limited. The objective of this research was to provide an insight 
into the potential for South African herbivores to serve as reservoirs or vectors for antibiotic 
resistant Escherichia coli. The antibiotic resistance profiles for E. coli isolated from wildebeest, 
zebra and giraffe faeces were established, in addition to resistance profiles of E. coli from both 
pet and farm pig faeces. A standard MPN guideline procedure was used to quantify and isolate 
total and faecal coliforms and E. coli. Twelve antibiotics representing seven antibiotic classes 
were selected, and profiles for 30 confirmed E. coli isolates per animal were determined using 
the European Committee on Antimicrobial Susceptibility Testing (EUCAST) disk diffusion 
procedure.  
The log10MPN values per gram of animal faeces for total/faecal coliforms were between 
4.51/4.11 and 5.70/5.50 log10MPN/g, while the results for E. coli were in the range of 3.23-
5.14 log10MPN/g for all animal faeces. There was no incidence of carbapenem or glycylcycline 
resistance for any of the 150 E. coli isolates; and only one farm pig E. coli isolate presented 
resistance to the fluoroquinolone antibiotics norfloxacin and ciprofloxacin. Antibiotics to 
which the largest proportions of resistance occurred were amoxicillin-clavulanic acid, 
ceftazidime and tobramycin. 47% of E. coli isolates from zebra were multidrug resistant (MDR, 
resistant to at least one antibiotic from three or more different classes), with no giraffe or 
wildebeest faecal E. coli isolates demonstrating MDR. Of E. coli isolated from farm and pet 
pig, 7% and 10% were MDR, respectively. 
Of 150 E. coli isolates screened for antibiotic resistance, 102 (68%) demonstrated resistance to 
at least one β-lactam antibiotic (ampicillin, amoxicillin-clavulanate, ceftazidime, aztreonam or 
a combination thereof). These isolates were screened for the presence of the β-lactamase gene 
blaTEM. The blaTEM gene was only detected in three farm pig E. coli isolates. All of these 102 
E. coli isolates were screened for β-lactamase activity using the colorimetric substrate 
nitrocefin, and the specific β-lactamase activity was determined for a selection of isolates. Of 
the tested β-lactam-resistant E. coli isolates, 64 were positive for β-lactamase activity (63%) 
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using nitrocefin as test substrate, with 38 isolates failing to hydrolyse nitrocefin (37%). The 
specific β-lactamase activity was determined spectrophotometrically for ten E. coli isolates 
from a combination of herbivore and pig faeces with diverse phenotypic resistance profiles and 
nitrocefin hydrolysis results. For those E. coli isolates unable to hydrolyse nitrocefin (2 pet pig 
isolates), the resultant specific activity was <1 nmol  min-1  mg-1. Five nitrocefin-positive E. 
coli isolates from herbivore faeces had specific activities of between 2 and 3 nmol  min-1  
mg-1, while the specific β-lactamase activity of three farm pig E. coli isolates containing the 
blaTEM gene was between 81 and 168 nmol  min-1  mg-1. 
The results of this study indicated that South African herbivores serve as reservoirs and thus 
potential vectors of antibiotic resistant E. coli. Furthermore, this study confirmed that 
companion (pet pig) as well as farm animals (farm pig) in South Africa may harbour antibiotic 
resistant bacteria, with some carrying β-lactam resistance determinants such as the blaTEM gene. 
Lastly, while an isolate may present phenotypic β-lactam resistance, it does not automatically 
indicate that a β-lactamase enzyme confers the resistance; but rather the presence of alternate 
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1. Antibiotic resistance 
Antibiotic resistance, or the ability of a microorganism to withstand the effects of such a drug, 
has developed into a global health issue, recognized and addressed by organizations including 
the World Health Organization (WHO), the Centres for Disease Control, the United States 
White House and the European Food and Safety Authority (EFSA 2012; Tadesse et al. 2012; 
WHO 2014; White House 2014). As a result, surveillance programs have emerged with the 
intention of estimating the extent of antibiotic resistance as well as tracking the evolution 
thereof.  
According to the WHO 2014 global antimicrobial resistance surveillance report (2014), high 
resistance rates are frequently observed in bacteria commonly associated with healthcare and 
community-acquired infections, across all WHO regions. This report amalgamated data from 
114 countries representing the six WHO regions including Africa, the Americas, Europe, 
South-East Asia, the Eastern Mediterranean and the Western Pacific. With regard to regional 
African data, there are significant gaps in surveillance for many countries, including South 
Africa, which is entirely absent from the report. Furthermore, the issue of global non-
consistency concerning methodology and data collection protocols presents a problem when 
surveillance data are compared. In the latest 2014 surveillance report, the African region was 
poorly represented with only 8 out of 47 member countries submitting data - a 17% 
participation rate (WHO 2014). The report highlighted that selected bacteria such as 
Escherichia coli are showing resistance to a combination of fluoroquinolones and third 
generation cephalosporins in a number of African countries. It further reported antibiotic 
resistance among Staphylococcus aureus and enteric bacteria including Klebsiella pneumoniae 
and Shigella spp. (WHO, 2014). It is widely accepted and acknowledged that the overuse of 
antibiotics in both human and veterinary medicine is a key reason for the increasing emergence 
of both resistant bacteria and the dissemination of matching resistance genes. In addition to 
indiscriminate antibiotic use among humans, the misuse of such agents in food animals is also 
a contributing factor to the horizontal transfer of resistance genes and thus the increase of 
antibiotic resistant bacteria (Allen et al. 2010; Wellington et al. 2013). The interconnectivity of 
factors including the environment, farming practices including animals and crops, wild and 


















Developing countries (including South Africa) are particularly affected by spreading antibiotic 
resistance. This is in part due to widespread poverty and lack of adequate sanitation and clean 
water (Schellack et al. 2011), which in turn can lead to untreatable common diseases. Farm 
animals, whether exposed through antibiotic prophylaxis or via growth-promoters, may serve 
as a reservoir for harmful antibiotic resistant zoonotic bacteria (Sørum and L’Abée-Lund 2002; 
Silbergeld et al. 2008; EFSA 2016). Direct human contact with the animals or ingestion of 
animal by-products may cause acquisition of infections caused by zoonotic antibiotic resistant 
bacteria [Figure 1] (Hammerum and Heuer 2009). Apart from emergence in clinical and farm 
environments, antibiotic resistance has also been observed in what would be considered 
“pristine habitats” - for example in unexposed environments including forests, deserts and 
savannahs. Primates, small mammals and birds of prey from such “pristine” environments have 
been analysed in recent years for the presence of antibiotic resistant bacteria (Rolland et al. 
FIGURE 1. Potential connections between farming practices, companion and wild animals, 




1985; Rwego et al. 2008; Radhouani et al. 2009 & 2012; Pesapane et al. 2013; Jobbins and 
Alexander 2015), with a variety of resistant and multidrug resistant (resistance to antibiotics 
from three or more different classes) bacterial phenotypes emerging. The monitoring of 
resistance profiles of bacteria isolated from animals in the “wild” is important as increased 
anthropological activity and encroachment into the habitats of wild animals could lead to an 
increase in interspecies disease transmission, involving hard to treat antibiotic resistant bacteria 
[Figure 1] (Katakweba et al. 2015). In addition, as animals inhabiting pristine environments 
could serve as reservoirs or vectors for the transmission of antibiotic resistant bacteria and 




2. Animals as reservoirs and vectors for the dissemination of antibiotic 
resistance 
The misuse of antibiotics in disease treatment has resulted in the development of resistances 
by bacteria (Radimersky et al. 2010). Although bacterial antibiotic resistance is widely 
observed in human and domestic animal populations, studies have acknowledged the presence 
of antibiotic resistance in commensal Escherichia coli isolated from wild animals not directly 
exposed to antibiotic treatment (Čížek et al. 2007; Literak et al. 2007; Radimersky et al. 2010; 
Vittecoq et al. 2016). Antibiotic agents exert a selective pressure on both pathogenic and 
commensal bacteria colonizing the human and animal gastrointestinal tract. The emergence 
and subsequent spread of resistances within and between bacterial genera can be attributed to, 
among other factors, the intensive use of antibiotic drugs in medicine, livestock production, 
agriculture and aquaculture (Silva et al. 2010; Graham et al. 2016). E. coli is a common hygiene 
indicator organism, useful to “track the evolution of antimicrobial resistance in different 
ecosystems” (van den Bogaard and Stobberingh 2000; Leclerc et al. 2001), and thus an 
excellent model organism for such studies. Although only certain strains of E. coli are 
pathogenic, E. coli may serve as a reservoir of antibiotic resistance genes with the potential for 
transfer to a variety of pathogenic bacteria. This in turn could result in diseases caused by 




The use of antibiotics in animals has been a long-standing global controversy, particularly with 
regard to those used for growth promotion or to increase feed-efficiency (Furtula et al. 2010). 
Similarly, certain classes of antibiotics including the β-lactams and fluoroquinolones have 
prominent use in human medicine, however these are further utilized in veterinary 
environments. The widespread and unrestricted use of antibiotics in human and animal 
environments causes selection of antibiotic resistant bacteria and the eventual emergence and 
distribution of these bacteria and their resistance genes throughout the food chain (Meyer et al. 
2013). Table 1 depicts selected antibiotic categories which are of importance in human and 
veterinary disease treatment as well as agriculture; and summarizes the modes of antibiotic 
action and the resistance mechanisms that have developed. 
 
2.1 Farm and companion animals 
The increasing demand and sheer scale of livestock production has resulted in an intensification 
of production systems, leaving no tolerance for the possibility of disease outbreak (Barton 
2014; Rushton 2015). Concurrently, Van Boeckel et al. (2015) predicted that the annual raising 
and consumption of pigs in China totals approximately half the entire planet’s pork industry. 







Mode of antibiotic 





Inhibition of cell wall 
biosynthesis 
Enzymatic inactivation of 
the antibiotic (β-
lactamases), and mutation 
of penicillin binding 
proteins; porins 
Fluoroquinolones Norfloxacin, Ciprofloxacin 
Inhibition of DNA gyrase 
during DNA replication 
Mutation of DNA gyrase 
and drug efflux 
Aminoglycosides Gentamycin, Tobramycin 
 Impairment of codon-
anticodon interaction 
causing accumulation of 
defect proteins 
Enzymatic inactivation/ 




Inhibition of protein 
synthesis (affect t-RNA 
binding to 30S ribosome) 
Efflux of drug and 
enzymatic inactivation of 
the antibiotic 
 




With the yield of pork increasing every year, the amount of manure produced increases, and 
thus the potential for excretion of antibiotic residues into the environment (Larson 2015). 
Antibiotic prophylaxis in such intense livestock production systems occurs for purposes 
including maintaining the health of the pigs as well as growth promotion, and although 
regulations to curtail antibiotic use have been implemented in many countries (Landers et al. 
2012), direct use of antibiotics in animal feed in many countries is still poorly controlled 
worldwide. A molecular typing study undertaken by Hu et al. (2013) involved E. coli isolated 
from pig faeces and nearby water sources. Results indicated that all isolates presented 
resistance to the cephalosporin antibiotic cefotaxime, and approximately 65% of isolates were 
resistant to the fluoroquinolone antibiotic ciprofloxacin (Hu et al. 2013). The latter in particular 
is a concerning statistic considering ciprofloxacin is a second-generation fluoroquinolone 
antibiotic with less than twenty years of FDA approved clinical use thus far (Goossens et al. 
2007). Moreover, the overuse of antibiotics by humans worldwide contributes to the 
introduction of antibiotic compounds into rivers via waste water treatment plants, as antibiotic 
residues are not sufficiently removed by waste-water treatment plants (Xu et al 2007). 
Consequently, an eventual dissemination of transferable antibiotic resistance genes may filter 
into drinking water supplies, surface water, rivers and dams - thus potentially impacting marine 
life or the recreational activities of humans [Figure 1] (Korzeniewska et al. 2013). 
There is a strong correlation between antibiotic use and the extent of antibiotic resistant E. coli 
isolated from livestock worldwide (Barton 2014). The use of antibiotics as growth promoters 
in swine is considered particularly controversial. Herein, the growth promoters are often of the 
same antibiotic families as those valuable or of critical importance in the treatment of human 
infections. The additives to pig feed are most often prepared by companies on the instruction 
of the farmer with no veterinary input (Barton 2014). The liberal use of such feed additives 
creates an ideal environment for selection of antibiotic resistant bacteria and the spread of such 
genes within the intestinal tract. Antibiotic growth promoters received a blanket ban by the 
European Union (for EU countries) in 2006, with other European countries following suit since 
(Maron et al. 2013). A second use of antibiotics in swine raising is prophylactic (individual 
animals receive antibiotic treatment) or metaphylactic (an entire pen receiving treatment) for 
the purpose of disease prevention (Barton 2014). A veterinarian-prescribed medicated feed is 
employed in a metaphylactic treatment plan, and is only utilized when a disease outbreak 




therapeutic reasons, where injections or an oral dose is administered to individual pigs in the 
case of specific bacterial infections. 
Due to the general absence of stringent guidelines as to the appropriate type of antibiotic to use 
and recommended dosage, widespread resistance has developed to agents including those 
belonging to the tetracycline, aminoglycoside, fluoroquinolone and penicillin classes (Hu et al. 
2013; Wasyl et al. 2013). Callens et al. (2012) reported that due to a lack of prudent prescription 
guidelines in Belgium, antibiotics used in agriculture were administered at inadequate doses, 
and moreover belonged to classes considered important in human medicine. In Denmark, 
prescription of tetracyclines increased between 2002 and 2008. However, due to increased 
surveillance and stricter guidelines, the prescription of both fluoroquinolones and 
cephalosporins decreased within the same time period (Vieira et al. 2011). Furthermore, 
through the elimination of non-therapeutic antibiotic use in agriculture and animal raising, there 
has been an observed decline in the detection of resistance genes including blaCTX-M in soils 
(Graham et al. 2016). In the United States, tetracyclines remain the most prescribed antibiotics 
in animal husbandry, with Canada mirroring this trend (Apley et al. 2012; Glass-Kaastra et al. 
2013). However, it is difficult to reliably quantify and describe antibiotic usage in animals in 
South Africa, as usage is controlled by two different national Acts, and sensitive information 
is closely guarded by pharmaceutical companies (Eagar et al. 2012). A 2012 study found that 
mean antibiotic sales for veterinary/agricultural use between 2002 and 2004 amounted to over 
1.5 million kilograms (~ 1500 metric tons) of active ingredient (Eagar et al. 2012). The global 
consumption of antibiotics in food animal production alone is projected to increase by 67% 
from 2010 to 2030, with approximately 95 million kilograms (~ 95 000 metric tons) of 
antibiotics consumed by 2030 (Van Boeckel et al. 2015). 
The use of poultry manure and litter as fertilizer has become common practice for farms in 
South Africa and overseas (Materechera 2010). In British Columbia (Canada), poultry litter is 
composted for use in organic crop farming and mushroom farming (Furtula et al. 2010). Of 
growing concern is the fact that growth-promoting antibiotics may be present in the manure, 
as many antibiotics are not fully absorbed by the animal gut and are thus excreted into the 
environment via the faeces [Figure 1] (Boxall et al. 2003; Kumar et al. 2005a). Veterinary 
pharmaceuticals present in the environment pose a potential health risk to humans, especially 
considering evidence suggesting that antibiotic agents may bioaccumulate in certain plants - a 




promoting antibiotics in feed may lead to a modification of the intestinal flora of poultry and 
other livestock, consequently creating a selective pressure favouring antibiotic resistant 
bacteria including E. coli. In turn, antibiotic resistant E. coli may be disseminated into the 
environment and food chain through faecal excretions and in the slaughtering and consumption 
process (Diarra et al. 2007; Furtula et al. 2010). Moreover, the avian intestine has been 
suggested to be a reservoir of E. coli with “zoonotic potential directly transferable to humans” 
(Ewers et al. 2009). Although E. coli is a commensal inhabitant of the human gastrointestinal 
system, pathogenic strains of E. coli have the ability to induce colibacillosis in chickens, as 
well as diseases including urinary tract infections, neonatal meningitis and septicaemia in 
humans (Amara et al. 1995; Ewers et al. 2004; Furtula et al. 2010). Some considerations with 
regard to attempts made to reduce the use of antibiotics in animals include the need to control 
infectious animals individually rather than employing a mass prophylaxis approach. In 
addition, housing and climate conditions of the animals should be optimized, and the level of 
biosecurity should be improved (Postma et al. 2016). 
Companion animals are of importance in global antibiotic resistance research, particularly due 
to the consistent intimate contact they have with humans, and thus their putative role in the 
spread of zoonotic resistant bacteria (Ewers et al. 2012). While traditionally companion 
animals referred to dogs and cats, the term now encompasses a much wider variety of animals; 
from rabbits and mice to ferrets, reptiles and freshwater fish (Damborg et al. 2015). Although 
kept for company or oftentimes psychological support, the potential for colonization with a 
variety of zoonotic bacteria - and the likely transmission to humans - is concerning (Damborg 
et al. 2015). In the last decade, the number of reports on community and veterinary-associated 
infections has steadily increased. Resistance to antibiotics belonging to the third generation 
cephalosporins, fluoroquinolone and carbapenem classes has been detected in bacteria isolated 
from companion animals comprising dogs and horses in countries including Germany, the 
Netherlands and Australia (Platell 2010; Ewers et al. 2012; Stolle et al. 2013; Baede et al. 
2015). Alternative antibiotic therapy has been suggested including glycopeptides and 
oxazolidinones, however as resistance emerges the antibiotic arsenal is reduced thus leaving 
few treatment options (Bengtsson and Greko 2014). A study analysing E. coli isolated from 
domesticated pets in China found almost 58% of isolates to be resistant to ciprofloxacin, a 
clinically important fluoroquinolone antibiotic (Yang et al. 2014). Moreover, resistance to 
antibiotics that have frequent use in farm environments (including fluoroquinolones) have been 




humans and companion animals (dogs, cats and horses) in Minnesota (USA), 31% presented 
resistance to tetracycline, of which 17% was attributed to isolates from companion animals 
(Bryan et al. 2004). Despite the scaling-back of β-lactam antibiotics for animal use in a number 
of countries (CDDEP 2016), resistance determinants including β-lactamase genes continue to 
emerge worldwide. The CTX-M enzymes (active on CefoTaXime, first isolated in Munich, 
elaborated upon later), in particular CTX-M-14, have been found to be the most prevalent type 
of β-lactamase enzymes detected in companion animal-sourced isolates from Asia (Ewers et 
al. 2012). Furthermore, the detection of two major β-lactamases, CTX-M-1 and SHV-12, were 
reported for the first time in E. coli from dogs and cats in Rome, Italy (Carattoli et al. 
2005). The first detection of a New Delhi Metallo-β-lactamase-encoding gene (NDM-1) from 
companion animals occurred in the United States in 2013, in a meropenem resistant E. coli 
isolate recovered from dog urine (Shaheen et al. 2013). This finding is particularly concerning 
considering carbapenems’ reputation as last resort drugs in human medicine, and emergence 
of resistance to such antibiotics may limit treatment options for humans who might contract E. 
coli infections from their pets (WHO 2012; Shaheen et al. 2013). 
 
2.2 Wild animals  
While indiscriminate antibiotic use in human and veterinary medicine is still considered a 
significant factor in the emergence and spread of antibiotic resistance, there has been particular 
focus on a potential co-emergence of resistant bacteria in animals and birds inhabiting wild 
(“pristine”) environments. Such animals have proven to be reservoirs of bacteria harbouring 
antibiotic resistance genes, and in addition serve as vectors for the transfer of zoonotic bacteria 
between other animals and humans (Allen et al. 2010). Considering that the lifestyle habits of 
wild animals include an unrestricted capacity for relocation and migration, it has thus become 
vital to screen and continually monitor bacteria isolated from such animals for resistance 
determinants. The following table presents a summary of wild animals and birds from which 






TABLE 2. Escherichia coli isolated from various wild animals in different countries and antibiotic 
resistance profiles detected. 








Canada Mice, Voles, Shrews AMP; CHL; FOX; SIA STR; STX; TET 
Kozak et al. 
2009 
Canada Mice, Voles, Shrews 
AMC; AMP; FOX; CEF; 
CFX; GEN; KAN; STR; STX; 
TET 
Allen et al. 
2011 
Germany Mice, Voles, Shrews AMP; KAN; STR; STX; TET; TIC 
Guenther et al. 
2010 
Vietnam Rats, Shrews AMP; AMC; CHL; CIP; TET; TMP 
Nhung et al. 
2015 
Portugal Rabbits AMP; CIP; CHL; GEN; TET; TOB; STR 
Silva et al. 
2010 
Botswana Banded Mongoose AMP; CEF; CHL; CIP; DOX; GEN; NEO; STR; STX; TET 
Pesapane et al. 
2013 
Tanzania Goat AMP; AMC; STR; STX; TET; TMP 
Mwanyika et 
al. 2016 
Mexico Mexican Free-tailed Bat AMP; NEO: STR Souza et al. 1999 
Mexico Howler Monkey AMP; AMC; CHL; CIP; STX; TET 
Cristóbal-
Azkarate et al. 
2014 
Australia Brush-tailed Rock-wallaby SPC; STR; TMP Power et al. 2013 
Italy Alpine Marmot STR; TET; SUL Caprioli et al 1991 
Canada Raccoons (rural & urban) 
AMC; AMP; CEF; CFX; 
CHL; CIP; FOX; GEN; NAL; 
SIA; STR; STX; TET; TMP 
Jardine et al. 
2012 




Wales Magpies AMP; CHL; KAN; TET; TMP Livermore et al. 2001 
Ireland Gulls PEN; STR; TET Carroll et al. 2014 
Portugal Seagulls 
AK; AMC; AMP; CHL; CIP; 




Portugal Raven CHL; STR; SXT; TET Pinto et al. 2010 
Japan Waterfowl AMP; CHL; DSM; KAN; OXY; SDMX 
Tsubokura et 
al. 1995 
     





A 2001 study by Osterblad et al. (2001) compared the faecal Enterobacteria of mice from rural 
England to those of Finnish wild deer, revealing that ninety percent of bacteria isolated from 
the mice were resistant to various β-lactam antibiotics whereas almost no resistance was 
observed in bacteria isolated from the Finnish deer. As a result of Finland being less densely 
populated than England, it may be inferred that human proximity and resulting anthropological 

















Czech Republic Wild Boars AMP; AMC; NAL; STR; STX; TET 
Literak et al. 
2010a 
Ireland Deer PEN; STR; TET Carroll et al. 2014 
Mexico Deer ATM; CAZ; CFX; CFZ; CPM; PIP 
Carrillo-Del 
Valle et al. 
2016 
South Africa Impala TET Mariano et al. 2009 
South Africa Impala AMP; CHL; STR Marè 1968 










Tanzania Wildebeest, Buffalo, Zebra AMC; AMP; CTX; ENO; GEN; STX; TET 
Katakweba et 
al. 2015 







Spain Iberian Lynx STR; STX; NAL; TET Gonçalves et al. 2013 
Portugal Iberian Wolf CHL; CIP; GEN; NAL; STR; SXT; TET; TOB 
Gonçalves et 
al. 2012 
United States Bottlenose Dolphin AMP; AMC; CHL; ERY; PIP; TET 
Schaefer et al. 
2009 
Poland Lion, Dingo, Wildcat (zoo) 
AK; AMC; AMP; CEP; CHL; 






* AK Amikacin; AMC Amoxicillin-clavulanic acid; AMP Ampicillin; ATM Aztreonam; CAZ Ceftazidime; CEF 
Ceftiofur; CEP Cephalothin; CHL Chloramphenicol; CFX Ceftriaxone; CFZ Cefazolin; CIP Ciprofloxacin; CPM 
Cefepime; CTX Cefotaxime; DOX Doxycycline; DSM Dihydrostreptomycin; ENO Enrofloxacin; ERY Erythromycin; 
FOX Cefoxitin; GEN Gentamicin; KAN Kanamicin; NAL Nalidixic Acid; NEO Neomycin; OXY Oxytetracycline; 
PEN Penicillin; PIP Piperacillin; SDMX Sulfadimethoxine; SIA Sulfisoxazole; SPC Spectinomycin; STR 
Streptomycin; STX Sulfamethoxazole/trimethoprim; SUL Sulphathiazole ; TET Tetracycline; TIC Ticarcillin; TMP 




Research by Silva et al. (2010) illustrated the antibiotic resistance of E. coli isolated from 
healthy wild European rabbits. As a recognised food source for both humans and other wild 
animals, it was deemed important to identify the resistance genes present, with the potential for 
transfer. E. coli isolates demonstrated resistance to ampicillin, tetracycline, streptomycin, 
gentamycin, tobramycin, ciprofloxacin and chloramphenicol, with resistance genes including 
blaTEM, aadA, aac(3)-II and tetA being detected (Silva et al. 2010). Some resistances detected 
in this study belong to classes of antibiotics utilized in human medicine, thus making the results 
obtained all the more concerning. Moreover, the failure to treat human diseases can contribute 
to longer infectivity periods thus increasing the severity of infections. 
As illustrated in Table 2, the detection of E. coli with antibiotic resistance may occur in 
numerous wild animal groups - from those with specific dietary and habitat patterns 
(carnivores, water-dwelling animals), to those encompassing wide-ranging lifestyle factors, for 
example omnivores or migratory birds. A study conducted by Jobbins and Alexander (2015) 
in Botswana surveyed the potential for antibiotic resistance in E. coli isolated from a variety of 
animals; both large and small herbivores and carnivores including African elephant, crocodile, 
spotted hyena, waterbuck, leopard and hippopotamus. At least one E. coli isolate from all 
above-mentioned animals was resistant to at least one (albeit unspecified) antibiotic (Jobbins 
and Alexander 2015). Moreover, a high variability of multidrug resistance was observed 
despite the apparently “pristine” wild habitat; largely attributed to dietary habits (whether 
conforming to an herbivorous, omnivorous or carnivorous diet), association with water (fully-
dependent or only for drinking water) and proximity to urban or anthropogenic areas (Jobbins 
and Alexander, 2015). Further proof of such a phenomenon was observed in a Czech Republic 
wild boar study undertaken by Literak et al. (2010a). Isolated faecal E. coli contained extended 
spectrum β-lactamases (ESBL), likely due to the omnivorous diet of the boars, and their 
tendency to consume human waste from encroaching anthropogenic habitats (Literak et al. 
2010a). Additionally, research concerning antibiotic resistance in African primates, wild birds 
and birds of prey has been conducted (Rolland et al. 1985; Rwego et al. 2008; Radhouani et al. 
2009 & 2012), with the detected resistances being attributed to proximity to human habitats 
and waste. Katakweba et al. (2015) conducted a study evaluating the antibiotic resistance 
profiles of E. coli isolated from buffalo, wildebeest and zebra in Tanzania. It was inferred that 
increased anthropological activity within the animal’s habitats resulted in a notable increase in 




In addition to mammals, wild birds have demonstrated the potential for dissemination of 
antibiotic resistance genes over great distances. Seasonal migration between habitats will also 
contribute to resistance gene dissemination (Allen et al. 2010). The feral pigeon population of 
Europe totals more than 9.3 million nesting pairs, with pigeons observed in both rural villages 
and large urban cities (Johnston and Janiga 1995; Hudec and Šťastný 2005). Their diet may 
consist of cereal grains and vegetable waste (Radimersky et al. 2010). Although feral pigeons 
would not be directly exposed to antibiotics, they may be considered potential reservoirs of 
antibiotic resistant enteric bacteria, as a result of their migratory habits and proximity to 
anthropogenic activity. Although E. coli present in pigeon gastrointestinal tracts would 
generally be considered innocuous, stress or adenoviral infection may result in the emergence 
of disease causing E. coli (Kimpe et al. 2002). In an Arctic bird study, 8% of E. coli isolated 
from gut samples presented resistance to at least one of seventeen antibiotics, with 4% of 
isolates resistant to four or more antibiotics (Sjölund et al. 2008). As a result of the “pristine” 
nature of an Arctic habitat as well as the fact that Arctic birds may migrate between six 
continents, the presence of these resistances illustrates the vast geographical distances 
resistance genes may travel (Allen et al. 2010).  
Observations that have been made regarding the detection of antibiotic resistance in pristine 
wild environments are that selective pressure (allowing for selection of antibiotic resistant 
bacteria) is more common at ground level; i.e. more likely to be found in animals that have 
frequent interaction with soil and earth (Cristóbal-Azkarate et al. 2014). Geophagy is a 
recognized practice performed by animals including herbivores (Mahaney et al. 1999); and the 
resultant potential uptake of secondary metabolites produced by soil microorganisms such as 
streptomycetes may cause antibiotic resistance in isolated enteric bacteria. 
As previously mentioned, proximity of animals to human activity will greatly increase the 
prevalence and potential for mobility of antibiotic resistant bacteria. Moreover, the awareness 
that humans, the environment, wild and companion animals and farming practices are not 
isolated domains but rather a complex interconnected network is integral in understanding the 
issue of antibiotic resistance [Figure 1] (Calistri et al. 2013; Cantas and Suer 2014; Cristóbal-
Azkarate et al. 2014). While the habitat of wild animals may be envisioned as “pristine” with 
no direct antibiotic usage, the flooding of septic tanks or runoff of storm-water may cause entry 
of human faecal material into waterways and soil of such habitats (McCarthy et al. 2004). 




(aquatic or semi-aquatic life-history) led to a greater level of multidrug resistance being 
observed, as was the case in bacteria isolated from crocodile, hippopotamus, otter and 
waterbuck faeces in a study from Botswanan (Jobbins and Alexander, 2015). Such resistances 
were attributed to the exposure and consumption of water by the animals, as well as water-
associated vegetation and sediment. Similarly, a local study that took place in the Kruger 
National Park (South Africa) inferred that surface water bodies (e.g. watering holes) could be 
a source of antibiotic resistance and thus allow for spread of tetracycline resistance genes to 
previously unaffected animal populations, in this case to impala (Mariano et al. 2009). 
 
3. Antibiotics employed in animal medicine and agriculture and relevant 
resistance mechanisms 
Antibiotics, since the first discovery of the activity of Penicillin-G in vitro by Alexander 
Fleming in 1929, have revolutionised medicine and for a period of time, were viewed as a 
miracle invention (Fleming, 1929). While several antibiotic classes comprising many antibiotics 
have emerged over the years, there has been a significant innovation gap for antibiotic 











FIGURE 2. Timeline illustrating the discovery of prominent antibiotic classes and examples, emphasizing 
the innovation gap between ~1972 and 2000 




This, in conjunction with emerging resistance mechanisms, means antibiotics cannot be viewed 
and applied in the same indiscriminate way as before. Moreover, antibiotic use in animals has 
far-reaching consequences, further than simply that of the animal itself or the habitat it 
occupies. It is particularly concerning in agricultural settings, as dissemination of resistance 
determinants into the food chain impacts humans upon consumption or interaction with such 
animals. However, it is not only animals incorporated in the food chain that play a role in the 
spread of antibiotic resistance, but even birds and wild animals devoid of direct human contact. 
Antibiotics that have found extensive (though often justified) use in humans and animals (both 
the agriculture and veterinary sectors), in conjunction with the relevant resistance mechanisms 
that have subsequently emerged will be briefly addressed in this section.   
 
3.1 β-Lactams 
The β-lactam antibiotics represent one of the most highly utilized classes of antibiotics with 
widespread use in both human and veterinary medicine. Henton et al. (2011) reported that 
between 2002 and 2004 in South Africa, the β-lactam antibiotics encompassed more than 11% 
of all antibiotics sold. The report further commented on usage indicators, and that these 
antibiotics were most frequently utilized as growth promoters in poultry and pigs (Henton et 
al. 2011; Eagar et al. 2012). It has been established that β-lactam antibiotics are most commonly 
prescribed in Europe in the veterinary sector, with a decrease in livestock prescription having 
been observed over time (NORM/NORM-VET 2010; Guenther et al. 2011; DANMAP 2013).   
The β-lactam family consists of four major groups of antibiotic agents: penicillins, 
cephalosporins, monobactams and carbapenems [Figure 3]. All antibiotics within the four 
groups contain a β-lactam ring; with the classes being differentiated by their additional 
structural moieties viz. a thiazolidine ring for penicillins and a dihydrothiazolidine ring 
structure with the sulphur atom replaced by a carbon plus a double-bond between carbon 2 and 
3 for the carbapenem antibiotics. The cephalosporins have a dihydrothiazine ring attached to 
the β-lactam ring, and the monobactams comprise a monocyclic β-lactam molecule (Birnbaum 
et al. 1985; Neu 1986; Donowitz and Mandell 1988; Drawz and Bonomo 2010). Clavulanic 
acid, although not an effective antibiotic on its own, when combined with antibiotics of the 













The mechanism of action of β-lactam antibiotics is the inhibition of bacterial cell wall 
biosynthesis, through inhibition of transpeptidation (Drawz and Bonomo 2010). The cell wall 
consists of a peptidoglycan layer, which in the case of Gram negative bacteria is located 
between the outer and the cytoplasmic membrane, maintaining the cell shape and protecting 
against osmotic forces (Schleifer and Kandler 1972; Guenther et al. 2011). The β-lactam ring 
[Figure 3] of the antibiotics is sterically similar to the terminal D-alanine-D-alanine residue in 
the N-acetylmuramic acid (NAM) pentapeptide (a constituent of bacterial peptidoglycan). As 
a result of the similarity, the penicillin binding proteins (PBPs), such as transpeptidase, pair 
with the β-lactam antibiotics, thus causing acylation and inhibition of the transpeptidase 
enzyme, rendering further cell wall synthesis impossible (Fisher and Mobashery 2009; Drawz 
and Bonomo 2010). Attachment of the β-lactam antibiotic to certain penicillin binding proteins 
induces release of cell wall hydrolases and increased permeability and eventual deterioration 
of the cell wall (Zapun et al. 2008). The β-lactam family includes the first ever discovered 
antibiotic, penicillin-G (Fleming, 1929), as well as those that are more recent including the first 
to fourth generation cephalosporins (Guenther et al. 2011).  
 









The hydrolysis of β-lactam antibiotics by β-lactamase enzymes is a primary mechanism of 
resistance for such antibiotics. Over 400 β-lactamase enzymes are currently specified, with all 
of these enzymes showing the same underlying catalytic activity - hydrolysis of the β-lactam 
ring, but with varying substrate specificity and susceptibility to β-lactamase inhibitors 
(Guenther et al. 2011). A number of β-lactam antibiotics are considered a preferred first line of 
defence for several infections caused by Gram positive and negative bacteria, however the rise 
in resistance to these antibiotics has resulted in a predicted reduction of their efficacy to zero 
by 2023 (Wellington et al. 2013). A variety of β-lactamase enzymes have been characterized 
from E. coli isolates and have been assigned to specific classes using the Ambler and 
Bush/Jacoby/Medeiros schemes [Table 3]. 
TABLE 3. Summary of major β-lactamase enzymes found in Escherichia coli according to 
the Ambler and Bush/Jacoby/Medeiros classification schemes 
Ambler 







Enzyme types and examples 




ESBL * TEM, SHV, CTX-M 
Carbapenemases KPC, GES, SME 
















a Ambler et al. 1991 
b Bush et al. 1995; Bush and Jacoby 2010 
* ESBL - Extended Spectrum β-lactamase 
 
 
3.1.1.1 Extended spectrum β-lactamases: TEM, CTX-M and SHV 
Extended spectrum β-lactamases (ESBLs) are hydrolytic enzymes produced by some 
Enterobacteriaceae with the capability of inactivating numerous extended-spectrum β-lactam 




2009). ESBLs were first reported in the mid-1980s, and although initially only detected in K. 
pneumoniae and E. coli, they are now found in numerous other species (Bradford 2001; Mesa 
et al. 2006). Although a large portion of research is dedicated to ESBLs produced by 
Enterobacteriaceae isolated from nosocomial human samples, there has been evidence of such 
from community-acquired human, companion and wild animal samples (Otero et al. 2003; 
Brinãs et al. 2005; Mesa et al. 2006). Extended spectrum β-lactamases derived from the original 
TEM or SHV-1 type β-lactamases occur through point mutations in the parent enzymes (Jacoby 
and Munoz-Price 2005). A number of clinically relevant ESBL enzymes exist today, including 
but not limited to the TEM, SHV and CTX-M types. 
The TEM-type β-lactamase was originally discovered in an E. coli isolate from a Greek patient 
named Temoneira in 1965 (Datta and Kontomichalou 1965). More than 200 TEM-type β-
lactamases have since been characterised, a large proportion of which are extended spectrum 
β-lactamases (Kocsis and Szabó 2013). All TEM-type β-lactamases are point mutation 
derivatives of the TEM-1 types (Smet et al. 2008). A number of research groups have described 
the existence of CMT (“complex mutant TEM”) type enzymes, which have the ability to 
hydrolyse even 3rd generation cephalosporins and β-lactamase inhibitors, for example 
cefotaxime and clavulanic acid respectively (Fiett et al. 2000; Neuwirth et al. 2001). The 
origins of TEM β-lactamases vary widely, with such ESBLs being detected in clinical 
environments like hospitals and nursing homes (Sabaté et al. 2002), as well as in animals and 
food sources (Shooter et al. 1971; Prats et al. 2003; Brinãs et al. 2005). However, even wild 
animals have been sources for TEM type β-lactamases, evidenced by the detection of the TEM-
1 enzyme in E. coli isolated from foxes and birds of prey in Portugal (Costa et al. 2006), wild 
geese from Belgium (Garmyn et al. 2011), and waterbird faeces from the Baltic Sea coast of 
Poland (Literak et al. 2010b). 
The first report of a CTX-M ESBL was from an E. coli strain isolated from a laboratory dog in 
1989 (active on CefoTaXime, first isolated in Munich) (Matsumoto et al. 1988; Peirano and 
Pitout 2010). A worldwide dissemination of CTX-M producing Enterobacteriaceae has since 
been observed, with subtypes CTX-M-1 and CTX-M-9 occurring most frequently in clinical 
environments and agriculture. There have however been observations of rarer CTX-M types 
including CTX-M-2, 8 and 14 in pigs, cattle and other livestock from countries including Japan, 
Spain and Denmark respectively (Cavaco et al. 2008; Shiraki et al. 2004; Escudero et al. 2010). 




detected in Enterobacteriaceae isolated from pigs and proximate humans, suggesting such 
CTX-M-producing strains may span niches including the environment, community as well as 
wild animals (Dohmen et al. 2015). E. coli carrying CTX-M type β-lactamases have been 
detected in poultry and rabbit faeces in Spain (CTX-M-9 and 14) (Blanc et al. 2006), swine 
faeces in China (CTX-M-1 and 9) (Hu et al. 2013), in E. coli isolated from Glaucous winged 
gulls in Russia (CTX-M-15) (Hernandez et al. 2010) and E. coli isolated from rats in Germany 
(CTX-M-9) (Guenther et al. 2012). 
The SHV-type β-lactamases were first identified by Pitton (1972) as a derivative of a 
chromosomal penicillinase isolated from K. pneumoniae. The SHV β-lactamases are plasmid 
encoded, and over 23 variants exist, most of which possess extended spectrum activity against 
3rd and 4th generation cephalosporins and monobactams (Arakawa et al. 1986; Tzouvelekis and 
Bonomo 1999). Furthermore, many SHV-type β-lactamases share functional and structural 
similarity with TEM β-lactamases [Table 3]. Although frequently observed in K. pneumoniae, 
clinical E. coli strains on occasion present SHV-type ESBLs (Ling et al. 1994). Although there 
is no clear geographical pattern of distribution, the SHV-type β-lactamases are most often 
observed in highly selective nosocomial and ICU environments (Sanders and Sanders 1992). 
However, detection in livestock samples (including E. coli from poultry meat in Tunisia) has 
been reported (Jouini et al. 2007). With regard to wild environments, SHV-type enzymes have 
been observed in E. coli isolated from wild birds; including black-headed gulls from the Czech 
Republic (SHV-2 and 12) (Dolejska et al. 2009), Blackcap warblers from the Azores 
Archipelago (SHV-12) (Silva et al. 2011), and wild geese from Belgium (SHV-12) (Garmyn 
et al. 2011). Moreover, the SHV-12 enzyme was detected in E. coli isolated from Iberian wolf 
faecal samples [Table 2] (Gonçalves et al. 2012), as well as in E. coli from Norwegian rat 
faeces (Čížek et al. 1999). In addition to E. coli, the SHV-12 enzyme has been detected in 
Citrobacter freundii isolates from healthy swine faeces in Portugal (Machado et al. 2008). 
 
3.1.1.2 Carbapenem hydrolysing enzymes: KPC and MBL 
Carbapenem hydrolysing enzymes (carbapenemases) are a class of β-lactamases belonging to 
classes A, B and D designated by the Ambler system of classification, and classes 1 and 2 
according to Bush/Jacoby/Medeiros classification [Table 3]. The enzymes have the ability to 




KPC (Klebsiella pneumoniae Carbapenemase) is dominant among carbapenem hydrolysing 
enzymes in terms of ubiquity (Yigit et al. 2001). This enzyme (belonging to Ambler class A 
and Bush/Jacoby/Medeiros class 2f, Table 3) has a broad substrate spectrum including third 
generation cephalosporins, carbapenems and aztreonam (Bush and Fisher 2011). The KPC 
carbapenemases have been commonly associated with multidrug resistant Gram negative 
infection outbreaks, with particular attention paid to those occurring in hospitals. The 
epidemiology of KPC enzymes has included countries as far apart as the United States and 
Israel, with global spread being observed in recent years (Bratu et al. 2005; Leavitt et al. 2007; 
Wei et al. 2007). 
The MBL enzymes (Metallo-β-Lactamases) belong to Ambler Class B and 
Bush/Jacoby/Medeiros group 3a [Table 3] (Kocsis and Szabó 2013). With regard to 
Enterobacteriaceae, metallo-β-lactamase genes are transferred via plasmid conjugation 
(Kocsis and Szabó 2013). The first detected MBL was the IMP (active on IMiPenem) 
phenotype in 1991, from Pseudomonas aeruginosa, which was detected a few years later in 
Enterobacteriacea (Watanabe et al. 1991; Osano et al. 1994). Currently, the most important 
MBL enzyme is the New-Delhi Metallo-β-lactamase or NDM enzyme, first reported by Yong 
et al. in 2009. The first report originated from a carbapenem resistant K. pneumoniae strain 
isolated from a Swedish patient afflicted with a urinary tract infection, following travel to New 
Delhi, India (Yong et al. 2009). The isolate possessed metallo-β-lactamases, but was negative 
for all previously known MBL genes (Yong et al. 2009). NDM-1 has since been isolated from 
a number of K. pneumoniae and E. coli isolates spanning several countries, often associated 
with travel to India, and usually related to clinical cases involving invasive hospital treatment 
or extended nursing home stays (Kumarasamy et al. 2010; Poirel et al. 2014; Tijet et al. 2015; 
Park et al. 2016). Furthermore, detection of NDM type enzymes in E. coli from companion 
animals has occurred, including NDM-1 from dogs and cats in the USA (Shaheen et al. 2013), 
and NDM-9 in an E. coli isolate from a dog in Algeria (Yousfi et al. 2015). The detection of 
such enzymes in isolates from wild animals is rarely reported, however one study described 
the presence of the NDM-1 enzyme in a Salmonella enterica subsp. enterica serovar Corvallis 





3.1.2 Porins and efflux pumps 
Water-filled pores are present in the outer membrane of bacteria, serving the purpose of 
facilitating the movement of hydrophilic molecules including nutrients into the periplasmic 
space of the cell (Koebnik et al. 2000).  The proteins that cause formation of these channels are 
called porins, and were first described in E. coli in 1976 (Nakae 1976). Porins serve as a 
molecular “sieve” rendering the outer membrane permeable to certain hydrophilic compounds 
(smaller than a specific size exclusion limit), determined by the diameter of the channels 
present. There are multiple porin classes, ranging from general porins (involved in permeability 
of the cell), specific porins that may enable the uptake of specific molecules, and iron-regulated 
outer membrane proteins involved in enabling uptake of iron complexes via siderophores 
(Fernández and Hancock 2012). 
Bacterial cells may have up to 106 porins per cell (Achouak et al. 2001), with exclusion limits 
approaching that of the size of many antibiotics thus limiting the diffusion rate. To gain entry 
into a cell, antibiotics must first pass through the outer membrane barrier, provided one is 
present in the target bacterium (Hancock 1984). One such route is through porins, the number 
and type of which will determine the permeability and thus the antibiotic resistance or 
susceptibility of the cell. Mutations in porin encoding genes will affect the expression and 
structure of porins and thus directly impact the susceptibility of bacteria to antibiotics, either 
through the loss of the porin, lower level of expression or modification in the size or charge of 
the porin channel. The earliest example of porin-mediated resistance was reported in 1981, 
with the OmpF porin conferring resistance in E. coli K12 mutants against β-lactam antibiotics 
including carbenicillin (Harder et al. 1981). Beceiro et al. (2011) described clinical E. coli 
isolates resistant to cefpirome and cefepime, lacking OmpC and OmpF concomitant with 
increased levels of TEM-1 and OXA-1 β-lactamase (Beceiro et al. 2011). Any mutations 
causing the loss or alteration of porins can impact resistance as the rate of entry of the antibiotic 
will be limited, thus enhancing the influence of secondary resistance mechanisms - if applicable 
(e.g. β-lactamases). 
Efflux pumps, present in both Gram positive and Gram negative microorganisms (van 
Bambeke et al. 2000; Piddock, 2006), can essentially be divided into two groups based on their 
specificity. Broad spectrum pumps export members of structurally distinct molecular classes, 
while the substrate specific pumps export only one type of molecule (Cox and Wright, 2013). 




type pump system, a resistance-nodulation division (“RND”) family, or multidrug efflux 
systems (Webber and Piddock, 2003; Piddock, 2006). The efflux pumps conferring intrinsic 
antibiotic resistance in Gram negative bacteria predominantly belong to the RND family. The 
“AcrAB-TolC RND” is an efflux system found primarily in E. coli strains, conferring 
resistance to various β-lactam antibiotics (Piddock, 2006). Because one efflux pump has the 
ability to mediate resistance to multiple structurally discrete antibiotics, inhibition of such a 
pump could restore the antibacterial effects of several antibiotics (Lomovskaya et al. 2001; 
Blair and Piddock 2009; Cox and Wright 2013).  
 
3.2 Fluoroquinolones 
The first report of transferable resistance to fluoroquinolones was published by Martínez-
Martínez et al. (1998). Three mechanisms of transferable resistance have been identified so far. 
The first involves Qnr protein families consisting of proteins Qnr (Quinolone resistance) which 
function to protect DNA gyrase and topoisomerase IV from quinolone antibiotics (Yang et al. 
2014; Poirel et al. 2012). The second transferable resistance mechanism is based on the 
aac(6’)Ib-cr gene, encoding an aminoglycoside acetyltransferase with the ability to acetylate 
fluoroquinolones with a piperazinyl substituent (Ruiz et al. 2012a; Yang et al. 2014). Another 
mechanism providing fluoroquinolone resistance is the activity of multidrug efflux pumps 
QepA and OqxAB, which confer increased resistance to agents including quinoxalines and 
fluoroquinolones (Rodriguez-Martinez et al. 2011; Yang et al. 2014). 
 
3.2.1 Qnr protein families 
Crystallography studies indicate that Qnr proteins are folded into a right hand β helix, with nine 
complete coils (Vetting et al. 2011; Ruiz et al. 2012a). Five families of Qnr proteins have been 
described: QnrA, B, S, C and D (Minarini et al. 2008; Jacoby et al. 2008; Wang et al. 2009; 
Ruiz et al. 2012a). Where the function of a quinolone antibiotic is to bind the DNA-enzyme 
complex, stabilize the cleavage and ultimately lead to lethal double-stranded breaks, the Qnr 
proteins have demonstrated binding to topoisomerase IV and DNA gyrase, thus destabilizing 




Robicsek et al. 2006; Quiroga et al. 2007; Jacoby et al. 2008; Guo et al. 2011). Origins of the 
Qnr families vary widely, with some being proposed to have derived from chromosomal 
ancestors of waterborne Shewanellaceae or Vibrionaceae (Poirel et al. 2005a). Moreover, the 
QnrA family presents >70% homology with four chromosomally encoded proteins of 
Shewanella algae (Poirel et al. 2005b). The detection of such qnr genes has occurred in E. coli 
isolated from a variety of animals including; waterbird faeces from the coast of Poland (qnrS) 
(Literak et al. 2010b), urban brown rats in Berlin (qnrB) (Guenther et al. 2012) and red foxes 
in Washington DC (qnrS) (Ahmed et al. 2007). 
 
3.2.2 Aminoglycoside acetyltransferase  
The AAC(6’)Ib-cr enzyme is a bifunctional acetyltransferase variant. The -cr variant in 
particular has two amino acid substitutions: Trp102Arg and Asp179Tyr, which are essential in 
the acetylation of quinolones (Jacoby et al. 2014). Agents to which such an enzyme presents 
activity include a variety of aminoglycoside antibiotics including amikacin, kanamycin and 
tobramycin, as well as fluoroquinolones including ciprofloxacin and norfloxacin (Robicsek et 
al. 2006). The corresponding aac(6’)Ib-cr gene is generally observed within a multiresistance 
plasmid, in a cassette as part of an integron (Jacoby et al. 2014). Although also found in 
organisms such as P. aeruginosa, prevalence of the aac(6’)Ib-cr gene is associated with 
Enterobacteriaceae and E. coli in particular; often more ubiquitous than qnr alleles (Pitout et 
al. 2008; Ruiz et al. 2012b; Ciesielczuk et al. 2013). In addition, the aac(6’)Ib-cr gene is 
commonly found in correlation with the extended spectrum β-lactamase CTX-M-15, 
particularly in E. coli isolates from nosocomial environments including urine and blood 
samples (Pitout et al. 2008; Baudry et al. 2009; Perilli et al. 2009). Although not widespread in 
wild animals, the aac(6’)Ib-cr gene has been detected in E. coli isolated from gulls from 
Portugal and Sweden (Vredenburg et al. 2014 ) and primates in China (Wang et al. 2012). 
 
3.2.3 Multidrug efflux pumps 
The multidrug efflux pump OqxAB was first identified as a member of the PMQR (plasmid 




resistance to the antibiotic olaquindox in E. coli isolated from farm pigs (Sorensen et al. 2003; 
Strahilevitz et al. 2009). Although the mode of action was initially related to conferring 
resistance to quinoxaline antibiotics, OqxAB has a considerable substrate specificity, including 
fluoroquinolones ciprofloxacin and norfloxacin, as well as other antibiotics like 
chloramphenicol, nalidixic acid and trimethoprim (Hansen et al. 2007). Plasmid mediated 
oqxAB have been observed primarily from clinical K. pneumoniae and E. coli isolates, however 
the gene was detected in E. coli from pigs inhabiting farms in China (Zhao et al. 2010). In 
addition, co-occurrence of oqxAB with genes associated with plasmid-borne CTX-M alleles is 
common (Liu et al. 2013). 
The second major efflux pump is QepA - a plasmid-encoded pump which controls the decrease 
in susceptibility to hydrophilic fluoroquinolones including ciprofloxacin and norfloxacin. Zhao 
et al. (2010) indicated that qepA positive E. coli isolates had a higher frequency of 
topoisomerase mutations than that of Qnr-producing isolates, inferring that efflux pumps 
(OqxAB and QepA) may favour the selection of high level quinolone resistance compared to 
those selected by Qnr proteins. 
The detection of qepA has been the subject of numerous studies involving E. coli isolates from 
clinical samples (human urine), swine manure and livestock (chicken spleen), from countries 
including Nigeria, China and South Korea respectively (Ogbolu et al. 2011; Xu et al. 2015; Oh 
et al. 2016). In addition, detection of the qepA gene in E. coli isolated from a gorilla in a 
protected nature reserve in the Central African Republic has occurred (Janatova et al. 2014).  
 
3.3 Aminoglycosides 
Aminoglycoside resistance is thought to have originated from the mutation of normal cellular 
genes, acquisition of resistance genes as well as from aminoglycoside producing organisms. 
Moreover, as discovered by Shaw et al. (1993), resistance may also arise when the regulation 
of usually quiescent cellular genes is altered to high-level expression. Primarily however, 
aminoglycoside resistance is frequently attributed to enzymatic inactivation by 





3.3.1 Aminoglycoside modifying enzymes 
The three aminoglycoside modifying enzyme classes causing inactivation of aminoglycoside 
antibiotics, include phosphotransferases (APH) catalyzing O-phosphorylation, 
acetyltransferases (AAC) catalyzing N-acetylation (as mentioned above in 3.2.2), and 
nucleotidyltransferases (ANT) catalyzing O-adenylation. Within these three categories exist 
more than 50 different enzymes, combinations of which have been found in both Gram positive 
and negative bacterial pathogens (Shaw et al. 1993; Davies and Wright 1997). With regard to 
acetyltransferases, four principal classes exist, which modify aminoglycosides in the 1-, 3-. 6’- 
and 2’- amino groups (Benveniste and Davies 1973; Lovering et al. 1987; Shaw et al. 1993), 
conferring resistance to a combination of gentamicin, tobramycin, amikacin, fortimicin and 
apramycin (Hedges and Shannon 1984; Shimizu et al. 1985; Lovering et al. 1987). Genes 
encoding aminoglycoside resistance (including aadA and strA) have been detected in E. coli 
isolated from gulls in the Czech Republic (Dolejska et al. 2009) and rodents in Canada (Allen 
et al. 2011). 
 
3.4 Tetracyclines 
Tetracycline antibiotics include a large variety of broad spectrum agents such as tetracycline, 
oxytetracycline and doxycycline, capable of inhibiting the growth of both Gram positive and 
negative organisms. These antibiotics act through blocking the binding of the aminoacyl tRNA 
to the A site of the 30S ribosomal subunit (Chopra 1985; Chopra and Roberts 2001). First 
discovered in the 1940s, tetracyclines have since found extensive use in agriculture and clinical 
and veterinary medicine, primarily due to the favourable antibiotic properties and absence of 
harmful side effects (Dancer et al. 1997; Chopra and Roberts 2001). Such extensive use of 
tetracyclines over the decades has allowed for the emergence of resistance, predominantly 
based on the genetic acquisition of tet genes (Paulsen et al. 1996; Chopra and Roberts 2001). 
A number of mechanisms conferring resistance to such antibiotics exist, including the presence 





3.4.1 Efflux proteins 
The tetracycline efflux proteins are considered the most ubiquitous method of tetracycline 
resistance. The proteins encoded by the tet efflux genes are membrane-associated, and allow 
for the export of tetracycline from the bacterial cell allowing for reduction of the intracellular 
drug concentration. All efflux genes belong to the major facilitator superfamily, and within the 
genus Escherichia, include tetA, tetB, tetC, tetD, tetE, tetI and tetY (Chopra and Roberts 2001). 
In addition, the Gram negative efflux genes are normally associated with conjugative plasmids, 
which often carry multiple other antibiotic resistance genes. This therefore means that selection 
for any one of the included resistance factors, selects for the plasmid, potentially leading to a 
dramatic increase of multidrug resistant bacteria (Falkow 1975; Levy 1992; Paulsen et al. 1996; 
Chopra and Roberts 2001). Tetracycline resistance genes are a common finding in E. coli from 
wild animals; inclusive of deer in the USA (tetB) (Bryan et al. 2004), wild boars in Europe 
(tetA and B) (Literak et al. 2010a) and a number of wild birds in Europe (tetA and B) (Literak 
et al. 2010b). 
 
3.4.2 Ribosomal protection proteins 
A number of cytoplasmic ribosomal proteins (e.g. TetM and TetO), act to protect the ribosomes 
from tetracycline, and thus confer resistance to antibiotics including doxycycline and 
minocycline (Burdett 1996; Taylor and Chau 1996; Chopra and Roberts 2001). The mechanism 
of action concerns the binding of the ribosomal protein to the ribosome, altering the 
conformation of the ribosome and preventing the binding of tetracycline antibiotics. Moreover, 
the spectrum of resistance in terms of number of tetracycline agents is larger than that seen 







4. Methods employed for antibiotic resistance detection 
Rapidity and precision are essential characteristics of diagnostic methods employed in the 
detection and classification of antibiotic susceptibility (Sundsfjord et al. 2004). Both genotypic 
and phenotypic methods can be used. Advantages of genotypic methods include the fact that 
the result is a matter of presence or absence of a particular resistance gene or integron, which 
can be detected using PCR-based methods if appropriate primers are available. Furthermore, 
by bypassing conventional culture methods, detection time as well as potential biohazard risks 
can be decreased (Sundsfjord et al. 2004). The major disadvantage of genotypic detection of 
antibiotic resistances not encountered in the disk diffusion method is the fact that screening is 
limited to known genes. Therefore, novel or unknown resistance mechanisms will go 
undetected (Sundsfjord et al. 2004). In addition, the genotypic detection of resistances will not 
provide information on expression of the resistance. False-positive and false-negative results 
due to the presence of silent or pseudogenes, or mutations in primer binding sites are therefore 
possible (Sundsfjord et al. 2004). 
 
4.1 Phenotypic methods 
4.1.1 Disk diffusion method 
A standardized disk diffusion method was first suggested by Bauer et al. (1966). It is a cost-
effective and time-efficient procedure to determine the antibiotic resistances of a wide range 
of organisms to various antibiotic compounds. The method involves the preparation of specific 
agar, generally Mueller-Hinton, followed by surface inoculation using the organism of interest 
(Bauer et al. 1966). Commercially available antibiotic-impregnated disks are then placed on 
the agar surface and incubated for a specified amount of time depending on the experimental 
guidelines being followed (Jorgensen and Ferraro 2009).  
Due to the immediate diffusion of the antibiotic out of the disk, a gradient is created wherein 
the highest concentration of the antibiotic is found closest to the disk (Bauer et al. 1966). 
Following the specified incubation time, the diameter of the area showing no growth (i.e. the 
“zone of growth inhibition”), is measured. This zone is a representation of the minimum 




and Ferraro 2009). Following consultation with standard pre-established breakpoint tables (for 
example EUCAST or CLSI), the tested isolate would then be classified as either susceptible, 
intermediate or resistant to the tested antibiotic (Jorgensen and Ferraro 2009; CLSI 2016; 
EUCAST 2016). Homogeneity as well as thickness or depth of the agar must remain strictly 
constant across all tests to ensure consistent diffusion of the antibiotic (Matuschek et al. 2013).  
Furthermore, physiochemical factors including the pH and hydration of the agar are important 
to ensure batch to batch consistency (Gould 1960). Furthermore, as recently addressed in 
several reports and international conferences, the quality of the antibiotic disks is integral in 
maintaining uniformity as well as obtaining correct and reliable results; as investigation has 
revealed significant differences in antibiotic activity in disks from a variety of manufacturers 
(Åhman et al. 2015; EUCAST 2015). It is thus imperative that in-house quality control testing 
is regularly performed for consistency in all laboratories utilizing the EUCAST guidelines and 
breakpoint tables (EUCAST 2015; Kahlmeter 2016). 
 
4.1.2 MIC broth dilution method 
Minimum Inhibitory Concentration (MIC), defined as the lowest concentration of an antibiotic 
that will result in inhibition of microbial growth after overnight incubation, has been previously 
described as a gold standard for determining an organism’s antibiotic susceptibility (Andrews 
2001). MICs may be utilized in diagnostic laboratories to confirm resistances, as well as in 
research institutions to determine in vitro activity of new antibiotics, for the establishment of 
breakpoints (Jorgensen and Ferraro 2009). Furthermore, the MIC method is utilized when other 
methods such as disk diffusion are not appropriate, as is the case when determining the 
susceptibility of coagulase-negative staphylococci to teicoplanin (Andrews 2001). 
Although the generation of a quantitative result in the form of the MIC is advantageous, this 
method can be tedious and both reagent and space expensive (Jorgensen and Ferraro 2009). 
MIC testing may therefore be miniaturized in the form of “microdilution” trays (96 well 
microtitre plates), where approximately 12 antibiotics can be tested in a range of 8 two-fold 
dilutions per tray (Phillips et al. 1991). Following appropriate incubation, the MIC of each 
antibiotic at each concentration is determined through spectrophotometric inspection of the 




4.1.3 Enzyme activity 
With the advancement of antibiotic resistance and the need for the development of rapid and 
definitive tests, several colourimetric and acidimetric tests have been devised. In particular, 
techniques exist for the detection and quantification of β-lactamase activity in bacteria. Some 
of these tests may serve purely as a screening method through the use of various “spot-tests”. 
However, others can quantify the amount of β-lactamase activity. Colourimetric assays have 
been regularly utilized since first description in 1968 (Sargent 1968), and have been improved 
to include flow cytometric methods (Sparbier et al. 2012; Farias-Ramos et al. 2013). 
One widely used method involves the use of nitrocefin, a chromogenic cephalosporin that 
undergoes a colour change from yellow to red upon hydrolysis of the β-lactam ring, first 
suggested by O’Callaghan et al. (1972). Biomass of colonies may be used for direct testing, 
where a colony sample of the organism is suspended in a mixture of nitrocefin and phosphate 
buffer, and a change in colour within 30 minutes at 30C denotes the presence of β-lactamase 
activity (Livermore and Brown 2001). Although predominantly used in fastidious Gram 
negative organisms, this method is not appropriate for detection of staphylococcal 
penicillinases and ROB-1 present in Haemophilus spp., as the uninduced β-lactamase levels 
are inadequate for a visible colour reaction (O’Callaghan et al. 1972; Livermore 1995; 
Livermore and Brown 2001).  
A second chromogenic substrate is CENTA, which is readily prepared from the (commercially 
available) antibiotic cephalothin. This substrate can be applied in kinetic studies of β-
lactamases as well as for detection in various crude extracts. CENTA is however not suitable 
for direct detection using agar plates or slides, as the absorption spectrum of the leaving group 
is not presented as a visible colour change (Bebrone et al. 2001). 
Iodometric tests utilize a reaction wherein iodine is reduced by the hydrolysis of 
benzylpenicillin yielding penicilloic acid, which in turn is decolourizes a starch-iodine complex 
(Livermore and Brown 2001). The method may be carried out by means of test tubes or drops 
on filter paper strips or glass slides. Following mixing of culture material with the iodine 
reagent, decolourization after 5 minutes denotes the presence of β-lactamase activity 
(Livermore and Brown 2001). This test is not as sensitive as the nitrocefin assay but is less 




Lastly, there may be implementation of pH dependent tests where a pH indicator, for example 
phenol red, is applied. As the hydrolysis of the β-lactam ring is generating a carboxyl group, 
causes acidification takes place which can be confirmed using a suitable pH indicator. Paper 
strips or glass test tubes may be used, and upon testing a change in colour to yellow (in the case 
of phenol red) indicates β-lactamase activity (Livermore and Brown, 2001).  
 
4.1.4 MALDI-TOF MS 
MALDI-TOF MS, (Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass 
Spectrometry), is considered an analytical method that can be implemented for antibiotic 
resistance detection. MALDI-TOF MS has been successfully used to detect β-lactamase 
enzyme proteins (Kostrzewa et al. 2013), as the cleavage of the β-lactam ring (the mechanism 
of action of a β-lactamase enzyme) is characterized by addition of a water molecule, which 
results in an increase of the molecular weight of the antibiotic (Kostrzewa et al. 2013).The 
reaction product is monitored by MALDI-TOF MS, and strains lacking β-lactamases would 
therefore not form product due hydrolysed ring cleavage (Sparbier et al. 2012). This technique 
has been successfully utilized for a number of β-lactam antibiotics including ampicillin, 
ceftazidime, cefotaxime, ertapenem and meropenem. Furthermore, the organisms that have 
been successfully analysed using this technique comprise representatives from various genera, 
including E. coli, K. pneumoniae, Salmonella spp., P. aeruginosa and Acinetobacter baumannii 
(Burckhardt and Zimmermann 2011; Hrabák et al. 2011; Sparbier et al. 2012; Kostrzewa et al. 
2013). 
An additional advantage of this method is the potential of identification directly from specimen 
samples (urine or blood cultures for example), thus increasing speed and efficiency of analysis 
(La Scola and Raoult 2009; Ferreira et al. 2010; Kostrzewa et al. 2013). MALDI-TOF MS has 
in addition been applied to monitor the effects of applying different antibiotics to resistant and 
susceptible bacterial strains. Limitations of this methods may include the presence of new or 
unknown resistance mechanisms which may be overcome to some degree through the use of 





4.2 Genotypic methods  
4.2.1 Polymerase chain reaction (PCR) 
The Polymerase Chain Reaction (PCR) was first described almost thirty years ago by Mullis 
and Faloona (1987), and only one year thereafter was first published as a method for diagnostic 
application (Saiki et al. 1988a). PCR involves three principle steps: denaturation of the DNA 
via heating, annealing of the primers and lastly elongation of the (target specific) primers by 
(originally) a thermostable DNA polymerase isolated from Thermus aquaticus (“Taq” DNA 
polymerase) (Saiki et al. 1988b; Fluit et al. 2001). PCR has been identified as a useful tool to 
detect antibiotic genes in organisms isolated from a wide range of environments (Sundsfjord 
et al. 2004).  
A multiplex PCR protocol can be implemented, wherein several primer sets can simultaneously 
detect several antibiotic resistance genes in a single PCR reaction. This is a time and cost-
efficient method for screening multiple samples against a variety of resistance genes 
(Henegariu et al. 1997; Bii et al. 2005). Moreover, a real-time PCR protocol allows for 
monitoring of the accumulation of the amplicon using labelled primers and fluorescing 
amplicons to provide detectable signals (Mackay 2004; Sundsfjord et al. 2004). The presence 
or absence of known β-lactamase genes can be detected through the use of PCR using 
specifically designed primers to amplify the target genes. 
 
 
5. Outlook  
Antibiotic resistance threatens the prevention and treatment of an ever-increasing spectrum of 
diseases and infections caused by bacteria. Although antibiotics are essential to save lives, the 
inappropriate way in which they have been applied over time has resulted in a number of 
previously manageable infections rendered untreatable. While antibiotic resistance is observed 
in environments with extensive antibiotic use or exposure to these compounds - for example in 
clinical settings - the emergence and dissemination of antibiotic resistance in farm and wild 
animal habitats is of tremendous concern. Furthermore, the identification of bacteria with 
similar resistance profiles in an array of diverse interconnected ecological niches substantiates 




discussed at an international level, with efforts aimed at reducing the amount of antibiotics sold 
and used. This is achieved through the implementation of policies for both sale and application 
of antibiotics in clinical and farm settings, many of which have already been brought into effect. 
While governmental (e.g. WHO, CDC, EU and the US White House) policies and reports 
promoting appropriate antibiotic use exist, it is in addition necessary to consider other strategies 
to tackle the issue of antibiotic resistance. Many of these institutions are therefore advocating 
a holistic approach, in accordance with the “One World, One Heath” initiative. The 
improvement of antibiotic resistance monitoring, sanitary measures in clinical and food 
production facilities, as well as stringent guidelines with regard to the use of antibiotics in food 
processing and animal raising will allow for reduction of antibiotic resistant bacteria and limit 
the emergence and dissemination of antibiotic resistant strains. 
Considering the knowledge gaps for South Africa regarding antibiotic resistances as illustrated 
by the WHO 2014 surveillance report, the research outlined in the following chapters sought 
to provide a first insight into the status of wild animals as a potential reservoir of bacteria 
exhibiting antibiotic resistance. This study therefore focused on indigenous South African 
animals inhabiting what would be considered a “pristine” habitat and screened for Escherichia 
coli from faecal samples of three selected indigenous herbivores from a local nature reserve in 
Pietermaritzburg, KwaZulu-Natal, South Africa. Furthermore, E. coli was isolated from faecal 
samples of farmed pigs and from a “pet” (domestic) pig.  
The resultant antibiotic resistance profiles of E. coli isolates were established by employing the 
EUCAST disk diffusion procedure. Thereafter, the results were verified using genotypic PCR 
screening for a selected β-lactamase gene, followed by qualitative and quantitative analysis of 
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Assessment of three indigenous South African herbivores as potential 
reservoirs and vectors of antibiotic resistant Escherichia coli 
 
Due to the limited data available on the presence of antibiotic resistant bacteria in faeces of 
wild herbivores in South Africa, this study analysed resistance patterns for Escherichia coli 
isolates from wildebeest, zebra and giraffe in addition to pet and farm pig faeces. Total and 
faecal coliforms and E. coli were quantified in faecal matter using a MPN guideline procedure. 
Antibiotic resistance profiles against twelve selected antibiotics representing seven antibiotic 
classes were determined for 30 randomly selected E. coli isolates from each animal using the 
European Committee on Antimicrobial Susceptibility Testing (EUCAST) disk diffusion 
procedure. While MPN values per gram of animal faeces for total/faecal coliforms ranged from 
4.51/4.11 to 5.70/5.50, the E. coli MPN values were in a range of 3.43-5.14. About 47% of E. 
coli isolates from zebra faeces were categorized as multidrug resistant (MDR), while for 
wildebeest and giraffe no MDR isolates were detected. In comparison, 10% of E. coli isolates 
from pet pig and about 7% from farm pig faeces presented an MDR phenotype. Although most 
MDR isolates were resistant to at least one β-lactam antibiotic, only one MDR isolate from 
farm pig faeces was resistant to both norfloxacin and ciprofloxacin, the two fluoroquinolones 
tested. However, no resistance was detected to the tested carbapenems and tigecycline. The 
results of this study indicate that indigenous South African herbivores may serve as potential 





The extensive use of antibiotic compounds in human and veterinary medicine has led to the 
presence of antibiotic residues in food and the environment (Welch 1957; Kümmerer 2003; 
Kemper 2008; Martinez 2009). Consequently, recent research has focused on the transfer and 
detection of antibiotic resistant microorganisms and their genes in the environment (Sørum and 
L’Abée-Lund 2002; Garcia-Alvarez et al. 2012). Only recently, the World Health Organization 
(WHO), the European Food and Safety Authority (EFSA) and even the President of the United 
States of America highlighted antibiotic resistance as a serious global health problem (EFSA 
2016; WHO 2014; White House 2014). As zoonotic bacteria can acquire resistance to 
antibiotics typically utilized in human and veterinary medicine, farm animals can serve as a 
potential reservoir for antibiotic resistant bacterial strains as well as potential vectors for 
transferring such resistant bacteria or their genes into the environment (Sørum and L’Abée-
Lund 2002; Silbergeld et al. 2008; EFSA 2016). Zoonotic bacteria presenting resistance to 
antibiotics critical in human medicine such as fluoroquinolones and 3rd and 4th generation 
cephalosporins are of particular concern, as they may compromise the effective treatment of 
infections in humans (Hammerum and Heuer 2009; WHO 2012). Humans can acquire 
infections with such antibiotic resistant zoonotic bacteria either via contact with animals or 
through ingestion of contaminated food products of animal and non-animal origin.  
Escherichia coli is an intestinal bacterium commonly associated with the digestive system of 
animals and therefore considered a useful hygiene indicator (Leclerc et al. 2001). However, 
pathogenic strains of E. coli can be a serious threat to public health as was observed in 2011 
and 2016, when Shiga-toxin producing strains of E. coli caused outbreaks in European 
countries, ultimately attributed to the consumption of sprouts made from contaminated 
fenugreek seeds (EFSA 2011) and soft cheese (Peron et al. 2016). The pathogenic E. coli strain 
causing the 2011 outbreak exhibited multidrug resistance (MDR) against ampicillin, 
ceftriaxone, streptomycin and tetracycline (King et al. 2012), further highlighting the problem 
of MDR E. coli.  
Antibiotic usage in the diets of food animals through prophylactic or therapeutic means can 
promote the horizontal transfer of antibiotic resistance genes (Silbergeld et al. 2008; 
Wellington et al. 2013), which might even take place in the absence of selective pressure 
imposed by the use of antibiotics (Allen et al. 2010). Human-livestock contact taking place in 




bacteria due to the close contact between the population and livestock (Rwego et al. 2008; 
Klous et al. 2016). Additionally, studies in South Africa by Schellack et al. (2011) indicated 
that social issues including widespread poverty and lack of access to safe potable water and 
proper sanitation might stimulate the dissemination of multidrug resistant bacterial strains. 
However, antibiotic resistant bacteria are even found in the faeces of wild animals, ranging 
from primates (Rolland et al. 1985) to rodents (Guenther et al. 2010), wild boars (Literak et al. 
2010) and various wild birds (Costa et al. 2008), with even extended spectrum β-lactamase 
(ESBL) containing E. coli being detected (Literak et al. 2010). It was assumed that the presence 
of such antibiotic resistant bacteria is most likely due to anthropogenic activities or contact 
with anthropogenic waste material; for example seagulls that scavenge food wastes (Cole et al. 
2005; Radhouani et al. 2009) or wild baboons feeding on human refuse (Rolland et al. 1985). 
The ribotyping patterns of E. coli isolates from seagulls in New Hampshire (USA) had a >90% 
similarity to those of E. coli strains isolated from proximate wastewater treatment plants and 
landfill sites (Nelson et al. 2008), suggesting a potential for transfer of faecal bacteria to 
recreational areas frequented by humans. Moreover, considering the ability of long distance 
migration, birds can act as efficient transporters for the dissemination of antibiotic resistant 
bacteria and mirror the spectrum of such microorganisms found in humans and human waste 
materials (Radhouani et al. 2009). 
Antibiotic resistance profiles of E. coli isolates from various African wild animals - ranging 
from buffalo, eland, and primates to the smaller mongoose and warthog - have been previously 
established and reported (Rolland et al. 1985; Skurnik et al. 2006; Pesapane et al. 2013; Jobbins 
and Alexander 2015; Katakweba et al. 2015). However, to the best of our knowledge, no 
information on the resistance profiles of E. coli from South African herbivores zebra, giraffe 
and wildebeest is available. To estimate the extent of antibiotic resistance among bacteria 
associated with these herbivores, which might serve as potential reservoirs and vectors, 
surveillance is necessary. Therefore, this study reports initial screening data pertaining to 
antibiotic resistance profiles in E. coli isolates from the three selected indigenous herbivores 







Materials and methods 
Sample collection 
Faecal samples of giraffe (Giraffa camelopardalis), zebra (Equus burchellii) and wildebeest 
(Connochaetes taurinus) were obtained from the Bisley Valley Nature Reserve 
(S29°66’18.99” E30°39’10.95”), while pig (Sus scrofa domesticus) faeces were collected from 
a commercial pig farm in KwaZulu-Natal and a private household (pig kept as a pet) situated 
in Pietermaritzburg (KwaZulu-Natal, South Africa). All samples were collected between 
February and May 2015 (the dry autumn season) using sterile, labelled plastic bags, and 
immediately transferred on ice to the laboratory with sample analysis taking place within 12 
hours. 
Quantification of total and faecal coliforms and Escherichia coli from faecal samples 
Enumeration of total and faecal coliforms as well as E. coli was carried out in a single analysis 
for each of the five faecal samples according to the Most Probable Number (MPN) guideline 
procedure MFHPB-19 (Health Canada 2002). Confirmation of presumptive E. coli isolates was 
done via biochemical confirmation (GIMViC) and by PCR as described previously (Gemmell 
and Schmidt, 2012). For the PCR based detection of the gadA (glutamate decarboxylase A) 
gene, cells were harvested by centrifugation (13 500 x g, 5 min) from 1 ml of overnight cultures 
of presumptive E. coli isolates (nutrient broth, 35°C, 120 rpm), re-suspended in 100 µl sterile 
water followed by DNA extraction using a simple freeze and thaw technique (Gemmell and 
Schmidt 2012). The amplification reactions using the primers reported by Kim et al. (2006), 
were done in 25 l volumes, containing 1.5 l template DNA, 0.5 l of each primer (10 M, 
Inqaba South Africa), 12.5 l 2x DreamTaq Green PCR Master Mix (Thermo Scientific) and 
nuclease free water (KAPA), with the following cycling conditions (Labnet MultiGene II 
thermocycler): initial denaturation at 94°C for 2 minutes followed by 25 cycles at 94°C for 30 
seconds, annealing at 55°C for 30 seconds, 72°C for 1 minute and a final extension cycle at 
72°C for 7 minutes. PCR products were analysed by electrophoresis on 1% (w/v) agarose gel 
with addition of SYBR® Safe stain (Life technologies) and visualized under UV light using a 
Gbox Chemi XRQ system (Syngene) and GeneSnap software. A ready-to-use 100 bp DNA 
ladder (KAPA) was used as size marker, E. coli ATCC 8739 served as positive PCR control 
with Salmonella Typhimurium ATCC 14028 and nuclease free water employed as negative 




Antibiotic susceptibility disk diffusion assay 
The disk diffusion method (Version 5, 2015) from the European Committee on Antimicrobial 
Susceptibility Testing (EUCAST 2015) was used to assess the antibiotic resistance patterns of 
all E. coli isolates. The following twelve antibiotics were tested employing ready to use 6 mm 
disks (Oxoid): ampicillin (AMP - 10 µg), amoxicillin-clavulanic acid (AMC - 20/10 µg), 
cefotaxime (CTX - 5 µg), ceftazidime (CAZ - 10 µg), ertapenem (ERT - 10 µg), meropenem 
(MEM - 10 µg), aztreonam (ATM - 30 µg), ciprofloxacin (CIP - 5 µg), norfloxacin (NOR - 10 
µg), gentamicin (GEN - 10 µg), tobramycin (TOB - 10 µg) and tigecycline (TIG - 15 µg). 
Antibiotics utilized in this study were categorized into antibiotic classes based on therapeutic 
relevance, as suggested by Magiorakos et al. (2012). For the disk diffusion assay, suspensions 
from each E. coli isolate were prepared from nutrient broth cultures after incubation at 35°C 
(120 rpm, 14 hours) and adjusted to approximately 2 x 108 cells per ml (corresponding to 
approximately 0.5 McFarland standard suggested by EUCAST) using a Helber type bacterial 
counting chamber (Marienfeld, Germany). 100 µl cell suspension was spread plated onto 
Mueller-Hinton (MH) agar (Oxoid) plates containing 25 ml of agar per sterile 90 mm Petri 
dish. Four different antibiotic test disks (adjusted for approximately 1 hour to ambient 
temperature), were firmly placed equidistantly onto the agar surface. Plates were sealed using 
Parafilm and incubated inverted in stacks of two at 35°C for 20 hours as specified (EUCAST 
2015). Inhibition zones were measured to the nearest mm using digital Vernier callipers 
(Marshall Tools, India) and analysed using the latest EUCAST antibiotic breakpoint tables 
(EUCAST 2016). All isolates were analysed in duplicate against all twelve antibiotics. 
Statistical analysis 
Fisher’s exact was used for analysis of the significant differences between the pairwise 
resistance profiles of E. coli isolated from various animals, by using SPSS for Windows 
(Version 23.0; SPSS Inc., Chicago, IL, USA). 
Chemicals 







In this study, both total and faecal coliforms as well as E. coli were quantified in faeces 
collected from zebra, wildebeest, giraffe, farm and pet pig. The MPN values of total coliforms 
for wild herbivores were in the range of 4.51 to 5.36 log10 MPN/g, while values for pig faeces 
were slightly higher at 5.50 and 5.70 log10 MPN/g [Table 1]. As expected, faecal coliform 
levels were lower than the corresponding total coliform values, ranging from 4.11 (wildebeest) 
to 5.50 log10MPN/g (pet pig). The log10MPN/g values for E. coli in zebra, wildebeest and 
giraffe faeces were 4.69, 3.43 and 4.89 log10MPN/g respectively, while the values for pet and 
farm pig faeces were slightly higher at 5.11 and 5.14 log10 MPN/g [Table 1].  
TABLE 1. Quantification of total and faecal coliforms and Escherichia coli (with 95% 





















Zebra 5.11 4.66 / 5.57 4.89 4.40 / 5.38 4.69 4.19 / 5.19 
Wildebeest 4.51 4.04 / 4.99 4.11 3.65 / 4.56 3.43 3.06 / 3.80 
Giraffe 5.36 4.89 / 5.83 5.11 4.66 / 5.57 4.89 4.40 / 5.38 
Farm pig 5.70 5.19 / 6.20 5.34 4.95 / 5.72 5.14 4.74 / 5.54 
Pet pig 5.50 5.03 / 5.97 5.50 5.03 / 5.97 5.11 4.66 / 5.57 
 
From each of the five tested animal faecal samples, 30 randomly selected confirmed E. coli 
isolates were further analysed for their antibiotic resistance patterns. In total 106 out of 150 
selected E. coli isolates from all animal faeces were resistant to at least one of the 12 antibiotic 
compounds tested [Table A1]. The highest proportion of E. coli isolates showing resistance to 
at least one of the twelve antibiotics tested was found in zebra faeces (93%) followed by isolates 
from pet pig and wildebeest faecal samples, with 90% and 80% resistance respectively. In 
contrast, isolates from farm pig and giraffe showed the lowest proportion of resistances with 
47% and 43%, respectively [Table 2]. More than half (56.6%) of all 106 E. coli isolates from 




followed by about 23% (24/106 isolates) with a combination of two antibiotic resistances. The 
remaining 22 E. coli isolates showed resistances ranging from three (19 isolates) up to even 
five (one isolate) antibiotic compounds. With a few exceptions (4 isolates), all antibiotic 
resistant E. coli isolates possessed resistance against at least one of the following tested β-
lactam antibiotics: ampicillin, amoxicillin-clavulanic acid, ceftazidime, cefotaxime or 
aztreonam [Table A1]. Of all antibiotics tested, amoxicillin-clavulanic acid was the least 
effective as a large proportion (94 isolates) of the resistant E. coli isolates obtained from all 
five animals showed resistance against this compound [Figure 1]. However, no resistances 
were observed for the two tested carbapenem antibiotics ertapenem and meropenem, the 
cephalosporin antibiotic cefotaxime and the glycylcycline tigecycline [Table A1]. 
Interestingly, only 6 out of all 106 resistant E. coli isolates were resistant to ampicillin, half of 
which were isolated from farm pig faeces [Table A1]. The proportion of ceftazidime resistant 
E. coli isolates from zebra faeces was clearly higher than that observed in all other animals 
[Figure 1]. Among the non β-lactam antibiotics tested, the least effective antibiotic was the 
aminoglycoside compound tobramycin and, to a lesser degree, gentamicin [Figure 1]. 
Noticeably, one out of all 150 E. coli isolates - from farm pig faeces - presented resistance to 
both ciprofloxacin and norfloxacin, the two fluoroquinolone antibiotics tested. 
TABLE 2. Prevalence of resistances and multidrug resistance (MDR) for Escherichia 
coli strains isolated from faeces of wild herbivores and pet and farm pigs. 
 
Animal faeces N a Resistant b 
Multidrug resistant 
(MDR) c 
Zebra 30 93% (28/30) 47% (14/30) 
Wildebeest 30 80% (24/30) 0% (0/30) 
Giraffe 30 43% (13/30) 0% (0/30) 
Pet pig 30 90% (27/30) 10% (3/30) 
Farm pig 30 47% (14/30) 7% (2/30) 
Total 150 71% (106/150) 13% (19/150) 
a   Number of E. coli isolates analysed 
b   % of E. coli isolates resistant to one or more antibiotics (number of isolates) 
c  % of E. coli isolates resistant to 3 or more antibiotics representing at least 3 different antibiotic 

















The prevalence of multidrug resistant (MDR) E. coli isolates - those showing resistance to 
antibiotics from three different classes - was considerably lower with 19 MDR isolates detected 
out of the total 150 E. coli isolates analysed [Table 2]. Approximately 73% (14/19) of these 
MDR isolates were obtained from zebra faeces, while the analysis of giraffe and wildebeest 
faeces resulted in no E. coli isolates with multiple drug resistance. The analysis of pet pig faeces 
established 10% (3 out of 30) MDR isolates. Interestingly, the proportion of MDR in E. coli 
isolates obtained from farmed pig was also in the lower range at about 7% (2 out of 30). The 
phenotypic resistance profiles for all multidrug resistant E. coli isolates are summarized in 
Table 3. Nearly all MDR E. coli isolates (18 out of 19) featured resistance against the antibiotic 
amoxicillin-clavulanic acid, and eleven isolates (8 isolates from zebra and 3 from pet pig) 
showed the same resistance profile of amoxicillin-clavulanic acid, ceftazidime and tobramycin 
(AMC-CAZ-TOB). One MDR E. coli isolate from farm pig faeces was resistant to five 
FIGURE 1.  Incidence of resistances observed against selected antibiotics for Escherichia coli 
isolates obtained from zebra, giraffe, wildebeest and farm and pet pig faeces. Antibiotics for which 
no resistance was detected (cefotaxime, ertapenem, meropenem and tigecycline) are not shown. 
AMP, ampicillin; AMC, amoxicillin-clavulanic acid; CAZ, ceftazidime; ATM, aztreonam; NOR, norfloxacin;  




different antibiotics: amoxicillin-clavulanic acid, ampicillin, aztreonam, norfloxacin and 
ciprofloxacin (AMC-AMP-ATM-NOR-CIP). Moreover, this was the only E. coli isolate 
displaying resistance to both fluoroquinolone antibiotics tested. 
 
However, high levels of intermediate resistance were observed for the aminoglycoside 
antibiotics gentamicin (136 isolates) and tobramycin (116 isolates), as well as for the β-lactam 
antibiotics ceftazidime (101 isolates) and aztreonam (98 isolates) [Table A1]. In contrast to 
this, only one E. coli isolate - from wildebeest faeces - presented an intermediate resistance 
phenotype for tigecycline. In addition, less than 10 isolates showed an intermediate phenotype 
for the carbapenem antibiotic meropenem and the fluoroquinolone antibiotics norfloxacin and 
ciprofloxacin [Table A1]. 
The pairwise comparison between the observed antibiotic resistances E. coli isolates from 
different animals showed that the number of resistant E. coli isolated from giraffe was 
significantly lower than that isolated from zebra for the antibiotics amoxicillin-clavulanic acid, 
ceftazidime and tobramycin; and zebra was significantly higher than wildebeest for 
amoxicillin-clavulanic acid [Table S1]. 
 
TABLE 3. Antibiotic resistance profiles detected for all multidrug resistant (MDR) 
Escherichia coli isolates from faeces of wild herbivores and pet and farm pigs. 
Host species (number of isolates) Phenotypic multidrug resistance profile 
Zebra (8); Pet Pig (3) AMC-CAZ-TOB 
Zebra (2) AMC-ATM-TOB 
Zebra (1) AMC-ATM-CAZ 
Zebra (1) ATM-CAZ-TOB 
Zebra (1) AMC-CAZ-GEN 
Zebra (1) AMC-ATM-CAZ-TOB 
Farm Pig (1) AMC-AMP-CAZ-GEN 
Farm Pig (1) AMC-AMP-ATM-NOR-CIP 
 
AMP, ampicillin; AMC, amoxicillin-clavulanic acid; CAZ, ceftazidime; ATM, aztreonam; NOR, 





This study compared the number of total coliforms, faecal coliforms and E. coli in faecal matter 
of the five different animals tested. As expected, the MPN values established for total and 
faecal coliforms were higher in faeces from all five animals than the values for E. coli, with 
the highest numbers detected in pig faeces. The level of E. coli in pet and farm pig faeces in 
this study was 5.11 and 5.14 log10 MPN/g respectively, which is similar to the maximum counts 
of 5.11 log10 CFU/g reported for E. coli in fresh pig slurry from a Bulgarian pig farm (Petkov 
et al. 2006). The numbers of E. coli that were established for faeces of zebra, giraffe and 
wildebeest in the present study were somewhat lower in a range of 3.43 to 4.89 log10 MPN/g 
faeces. A similar scenario was observed by Smati et al. (2015) when comparing E. coli counts 
in wild and domesticated animal faeces, which was attributed to the variation in diet. 
Katakweba et al. (2015) quantified E. coli in cattle and wildlife faeces in Tanzania, obtaining 
counts for E. coli in wildlife faeces that were consistently higher than those obtained for cattle 
faeces. These authors established E. coli counts in faecal samples as 4.25 log10 CFU/g for zebra, 
4.60 log10 CFU/g for wildebeest, 4.84 log10 CFU/g for buffalo and 3.14 log10 CFU/g for cattle. 
These values are almost identical to the values obtained for zebra (4.69 log10MPN/g), 
wildebeest (3.43 log10 MPN/g) and giraffe (4.89 log10 MPN/g) faeces from South Africa. 
In addition, the 30 E. coli isolates obtained each from zebra, giraffe, wildebeest, pet pig and 
farm pig faecal samples were analysed to establish their antibiotic resistance profiles against 
twelve antibiotics using the EUCAST disk diffusion assay. The degree of resistances to one or 
more antibiotics observed in this study varied from 43%, for E. coli isolates from giraffe faeces, 
to 93% for E. coli isolates from zebra faeces. Similarly, Katakweba et al. (2015) detected 
antibiotic resistant E. coli in wildebeest and zebra faeces in Tanzania, with resistances to 
ampicillin, amoxicillin-clavulanic acid, cefotaxime and gentamicin identified. These authors 
identified 58.8% of E. coli isolates from wildebeest, 47.6% from zebra and 38.7% from buffalo 
as ampicillin resistant. The highest proportion of ampicillin resistant E. coli isolates from the 
three South African herbivores was therefore 3.3% lower, but closer to the percentage value of 
9% reported for ampicillin resistant E. coli isolates from cattle in Serbia (Knezevic and Petrovic 
2008).  
In contrast to the data established for the South African pet and farm pig, higher rates of 
ampicillin resistance were detected in E. coli isolates from pet animals (dogs and cats) and 




resistance (Sáenz et al. 2001). However, resistance rates for amoxicillin-clavulanic acid in the 
current study were higher at over 70% among E. coli isolates from South African zebra and 
wildebeest, than amoxicillin-clavulanic acid resistance rates reported recently for wildebeest 
(14.7%) and zebra (11.9%) in Tanzania (Katakweba et al. 2015). Similarly, for pet and farm 
pig from South Africa, amoxicillin-clavulanic acid resistance for E. coli isolates amounted to 
80% and 43% respectively, while for pets and farm pigs from Spain only 6% of isolates were 
resistant to amoxicillin-clavulanic acid (Sáenz et al. 2001). As the EUCAST breakpoint tables 
(2016) do not provide an intermediate resistance category for ampicillin and amoxicillin-
clavulanic acid, intermediate resistance phenotypes were not established for these two 
antibiotics.  
E. coli isolates resistant to the cephalosporin antibiotic cefotaxime were not detected in the 
faeces from any of the five South African animals although this has been reported for E. coli 
isolates from herbivores in Tanzania (Katakweba et al. 2015). Similar to our results, cefotaxime 
resistance was not detected in pet and farm pigs analysed in Spain (Sáenz et al. 2001). However, 
resistant E. coli isolates were identified for the cephalosporin antibiotic ceftazidime and the 
monobactam antibiotic aztreonam. In the case of ceftazidime, this ranged from about 7% 
(wildebeest) to 53% (zebra) and for aztreonam from 0% (giraffe) to about 17% (zebra). While 
no resistance was detected for cefotaxime, the results of the EUCAST disk diffusion assays 
showed the presence of E. coli isolates displaying intermediate resistance to cefotaxime as 
defined by the breakpoint tables (EUCAST, 2016). Intermediate resistance phenotypes might 
indicate a likelihood of therapeutic failure under specific clinical treatment conditions (Rodloff 
et al. 2008). Therefore, the EUCAST expert rules suggest categorizing certain intermediate 
resistances as resistant to avoid potential treatment failure (Leclercq et al. 2013). It is therefore 
concerning that 32 out of 150 isolates exhibited intermediate resistance for cefotaxime and that 
98 and 101 out of 150 isolates showed intermediate resistance for ceftazidime and aztreonam 
respectively, particularly as these antibiotics are defined as critically important antibiotics by 
the WHO (2012).  
No resistance was observed for any of the 150 E. coli isolates against the carbapenem 
antibiotics meropenem and ertapenem. The absence of resistance is encouraging and might be 
attributed to the fact that carbapenems are intended for use in human medicine while their 
application in veterinary medicine should be avoided (WHO 2012; Poirel et al. 2014). Similar 




imipenem when analysing 112 E. coli isolates from a large range of wild animals from nature 
reserves in Portugal. However, 6 (meropenem) and 30 (ertapenem) out of 150 E. coli isolates 
with intermediate resistance were nevertheless detected in our study.  
Similarly, low numbers of resistant and intermediate phenotypes were detected for the 
fluoroquinolone antibiotics norfloxacin and ciprofloxacin [Figure 1 and Table A1]. The only 
incidence of resistance to both ciprofloxacin and norfloxacin was detected for one E. coli 
isolate from farm pig faeces, with two additional isolates from the same animal showing 
intermediate resistance for ciprofloxacin and a ciprofloxacin/norfloxacin combination, 
respectively. This is in line with Sáenz et al. (2001), who identified 3% of E. coli isolates from 
farm pigs as ciprofloxacin resistant, which may be due to the use of fluoroquinolones for 
treating food animals (Collignon 2005). Other E. coli isolates showing an intermediate 
phenotype for fluoroquinolones were mainly present in zebra faeces [Table A1], which is 
surprising as they are not under veterinary surveillance.  
For the E. coli isolates from South African wild herbivores and pigs, the resistance rates for 
tobramycin (30/150: 18 from zebra, 7 from pet pig, 3 from giraffe, one each from wildebeest 
and farm pig) were elevated while those detected for gentamicin (2/150: one each from zebra 
and farm pig) were clearly lower [Figure 1]. For E. coli isolated from zebra and wildebeest in 
Tanzania, 23.8% and 20.6% of isolates showed resistance to gentamicin while this amounted 
to only 3.2% in buffalo (Katakweba et al. 2015). For farm pigs Sáenz et al. (2001) reported that 
7% of E. coli isolates showed resistance to these two aminoglycoside antibiotics while a study 
from Serbia reported that only 1% of E. coli isolated from swine presented resistance to 
gentamicin and tobramycin (Knezevic and Petrovic 2008), which is in line with our results for 
farm pig faeces. The somewhat higher incidence of tobramycin resistance in pet pig isolates 
(7/30) might therefore be due to veterinary treatment or close contact to humans. It is 
noteworthy that the levels of intermediate resistance among all 150 E. coli isolates were 
particularly high for the aminoglycoside antibiotics gentamicin (about 91%) and tobramycin 
(about 77%), both of which are approved for use in veterinary medicine in South Africa (Eagar 
et al. 2012). Only three isolates from giraffe and one from farm pig were sensitive to both 
aminoglycoside antibiotics. 
Out of all 150 E. coli isolates analysed in this study, no isolate was resistant to tigecycline and 
only one isolate from wildebeest faeces presented an intermediate resistance phenotype. Sáenz 




from farmed pigs in Spain and Serbia were resistant to tetracycline, and tetracycline resistance 
was reported as well for E. coli isolates from impala (Mariano et al. 2009), wildebeest, zebra 
and buffalo in Africa (Katakweba et al. 2015). However, the antibiotic tigecycline used in our 
study is a newer generation tetracycline type antibiotic, having only received approval for use 
by the FDA in 2005 (Noskin 2005) and not usually considered for use in veterinary medicine 
(Papich 2012).  Even in the presence of tetracycline resistance, tigecycline evades common 
tetracycline resistance mechanisms (Fluit et al. 2005) although recent work demonstrated that 
mutations in tetracycline resistance genes can confer increased MIC (minimum inhibitory 
concentration) values for tigecycline in E. coli (Linkevicius et al. 2016). Nevertheless, among 
more than 360 clinical isolates of E. coli from South Africa, no tigecycline resistance 
phenotype was detected, highlighting the efficiency of this antibiotic (Kanj et al. 2014). 
Nearly half (46 out of 106) of the antibiotic resistant E. coli isolates obtained from faecal 
samples possessed resistance against more than one antibiotic, with a total of 19 isolates 
exhibiting multidrug resistance (MDR), hence presenting resistance to 3 or more antibiotics 
belonging to at least 3 different antibiotic classes. The highest MDR proportion among all 
animal samples was observed for zebra faeces with 47% (14 out of 30 isolates, Table 2) 
displaying such a phenotype. However, no MDR E. coli isolates were detected in faecal 
samples from wildebeest and giraffe. The remaining five MDR E. coli isolates came from pet 
pig (3 isolates) and farm pig (2 isolates) faeces. Other studies in Africa also showed a large 
variability in the degree of MDR among E. coli isolates from different wild animals. Pesapane 
et al. (2013) established 40% of faecal E. coli isolates from banded mongoose in the Chobe 
National Park in Botswana as MDR, attributing this to the close contact of mongoose with 
guest and staff accommodations of the National Park. Similarly, Jobbins and Alexander (2015) 
analysed resistance patterns of E. coli isolated from a variety of animals in Botswana, including 
herbivores such as giraffe, impala and waterbuck as well as carnivores such as leopard and 
spotted hyena. Similar to our results, no multidrug resistant E. coli were obtained from giraffe 
faeces (Jobbins and Alexander 2015). Moreover, the percentage of MDR isolates varied greatly 
among different animals in Botswana, with some exhibiting 100% MDR, as in the case of 
isolates from otter and spotted hyena faeces, and some with low to non-existent MDR 
phenotypes such as those isolated from warthog, impala and bushbuck faeces (Jobbins and 
Alexander 2015). The high variability of MDR prevalence between different animals was 
attributed to dietary factors such as whether the animal is naturally a herbivore, omnivore or 




resistance profiles (Jobbins and Alexander, 2015). Another study that surveyed the prevalence 
of MDR E. coli isolates among farm pigs from the Mekong Delta in Vietnam found almost 
87% of isolates displaying a multidrug resistant phenotype (Nhung et al. 2015). However, these 
authors additionally analysed the difference between the prevalence of MDR in wild mammals 
trapped on farms, versus those trapped in nearby forests and rice fields. The results indicated 
that MDR phenotypes were almost eight times more abundant among E. coli isolates from wild 
mammals trapped on farms than among those E. coli isolates from mammals trapped in forests 
or fields, again highlighting that antibiotic resistance is likely driven in part by antibiotic usage 
on farms and contact to humans. This matches a study from Canada, where levels of resistant 
E. coli from wild mammals trapped on a farm were more than five times higher than in wild 
animals trapped in natural areas (Kozak et al. 2009). In the present study, the proportion of 
antibiotic resistant E. coli in farm pig faeces was in the lower range with only 14 resistant 
isolates, which is similar to the number of isolates detected for giraffe but much lower than the 
pet pig resistance percentage of 90%, which included 3 MDR isolates. A possible reason for 
this comparably high percentage of antibiotic resistant E. coli isolates in pet pig faeces might 
be due to its close and regular contact with humans. In addition, the intensive care it receives 
(including regular veterinary care and possible treatments to maintain its health) is similar to 
the treatment companion animals such as dogs and cats receive, which is known to potentially 
elevate resistance levels among bacterial isolates (Guardabassi et al. 2004). 
Although the presence of antibiotic resistant bacteria in wildlife inhabiting habitats devoid of 
apparent antibiotic pressure may seem an unlikely phenomenon, such incidences were 
observed even decades ago. In 1978, Sato et al. analysed E. coli isolated from feral and kept 
pigeons, and discovered the presence of conjugative R-plasmids, conferring resistance against 
chloramphenicol. Furthermore, research by Tsubokura et al. (1995) reported the presence of 
antibiotic resistant E. coli in migratory waterfowl in Japan between the years of 1983 and 1986. 
Research concerning the resistance profiles of E. coli isolated from over 77 wild mammal 
species was carried out in Australia (Sherley et al. 2000), with a low but widespread prevalence 
of antibiotic resistance being observed. In the current study, the incidence of E. coli isolates 
from wild animals resistant to at least one antibiotic was remarkably high for those isolated 
from zebra (28/30) and wildebeest (24/30), with a much lower incidence detected in E. coli 




The presence of E. coli with extended spectrum β-lactamases (ESBL) in wild boars was 
attributed to the omnivorous diet of the wild boar and the tendency to consume animal and 
human waste (Literak et al. 2010). As residents of Pietermaritzburg and surrounds can visit the 
park for recreational purposes, the wild herbivores are potentially exposed to humans and 
human waste, enabling the transfer of resistant bacteria to the herbivores. In fact, even 
contaminated clothing or contamination of the animal keeper were suggested as vectors for the 
spread of antibiotic resistant bacteria (Bosman et al. 2014; Poirel et al. 2014). A recent study 
in Tanzania demonstrated that the presence of antibiotic resistant E. coli in zebra faeces was 
linked to frequent contact between the animals and staff and visitor lodging areas (Katakweba 
et al. 2015).  
An additional factor potentially contributing to the presence of antibiotic resistant E. coli in 
faeces from wild herbivores in the current study is the proximity of the wild animals to a horse 
stable adjacent to the Bisley Nature Reserve. Although zebra, wildebeest and giraffe are not 
known to receive antibiotic treatment, the horses in the stables - which might enter the nature 
reserve - likely receive regular veterinary attention. 
Only recently, herbicides such as glyphosate were identified as a factor causing elevated 
antibiotic resistance levels in bacteria (Kurenbach et al. 2015). Strains of E. coli and S. 
Typhimurium showed several fold higher MIC values for certain antibiotics after exposure to 
sub-lethal concentrations of both antibiotics (including ampicillin and tetracycline) and 
herbicides (Kurenbach et al. 2015). The use of such herbicides in domestic and agricultural 
settings in the proximity of the nature reserve or the application of such herbicides within the 
park might therefore induce antibiotic resistant phenotypes in bacteria present.  
Finally, it is well established that animals - including herbivores - perform geophagy, which 
might lead to the uptake of secondary metabolites such as antibiotics produced by 
microorganisms present in the soil consumed (Mahaney et al. 1999). This and the fact that 
zebra and wildebeest preferentially graze close to the soil - with possible exposure to human 
waste present - whilst giraffe would preferentially practice browsing leaves from trees, might 
explain to some degree why the level of antibiotic resistance was significantly higher in zebra 





The data obtained in this study show that wild herbivores from KwaZulu-Natal serve as 
potential reservoirs for antibiotic resistant and even multidrug resistant Escherichia coli strains. 
This may be due to association with anthropogenic activity and proximity to a neighbourhood. 
However, further research is required in order to address which factors are involved in 
establishing the presence of antibiotic resistant bacteria in the herbivores targeted in this study. 
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SUPPLEMENTARY TABLE S1. Pairwise comparison (Fishers exact test, two-tailed) of the antibiotic resistance profiles of Escherichia coli 
isolated from zebra, wildebeest, giraffe, pet pig and farm pig faeces resistant to twelve different antibiotics. * 
 
 AMP AMC CTX CAZ ATM ERT MEM NOR CIP GEN TOB TIG 
Zebra & 
giraffe >0.9999 0.0016 >0.9999 0.0006 0.0522 >0.9999 >0.9999 >0.9999 >0.9999 >0.9999 0.0001 >0.9999 
Zebra & 
wildebeest >0.9999 >0.9999 >0.9999 0.0001 0.1945 >0.9999 >0.9999 >0.9999 >0.9999 >0.9999 0.0001 >0.9999 
Zebra &  
pet pig >0.9999 >0.9999 >0.9999 0.1154 0.1945 >0.9999 >0.9999 >0.9999 >0.9999 >0.9999 0.0082 >0.9999 
Zebra &  
farm pig 0.6120 0.0169 >0.9999 0.0061 0.4238 >0.9999 >0.9999 >0.9999 >0.9999 >0.9999 0.0001 >0.9999 
Giraffe & 
wildebeest >0.9999 0.0006 >0.9999 >0.9999 >0.9999 >0.9999 >0.9999 >0.9999 >0.9999 >0.9999 0.6120 >0.9999 
Giraffe &  
pet pig >0.9999 0.0006 >0.9999 0.1042 >0.9999 >0.9999 >0.9999 >0.9999 >0.9999 >0.9999 0.2990 >0.9999 
Giraffe & 
farm pig 0.2373 0.5959 >0.9999 0.7065 0.4915 >0.9999 >0.9999 >0.9999 >0.9999 >0.9999 0.6120 >0.9999 
Wildebeest & 
pet pig >0.9999 >0.9999 >0.9999 0.0419 >0.9999 >0.9999 >0.9999 >0.9999 >0.9999 >0.9999 0.0522 >0.9999 
Wildebeest & 
farm pig 0.6120 0.0073 >0.9999 0.4238 >0.9999 >0.9999 >0.9999 >0.9999 >0.9999 >0.9999 >0.9999 >0.9999 
Pet pig & 
farm pig 0.6120 0.0073 >0.9999 0.3604 >0.9999 >0.9999 >0.9999 >0.9999 >0.9999 >0.9999 0.0522 >0.9999 
 









β-lactamase gene screening and determination of specific enzyme activity in 




Escherichia coli presenting resistance to at least one β-lactam antibiotic (ampicillin, 
amoxicillin-clavulanate, ceftazidime, aztreonam or a combination thereof), originating from 
faecal samples of wild herbivores (zebra, giraffe and wildebeest) and farm and pet pigs in 
KwaZulu-Natal, South Africa, were screened for the presence of one selected β-lactamase gene 
and β-lactamase activity. The blaTEM gene was detected in three farm pig E. coli isolates. All 
102 isolates were thereafter tested for β-lactamase activity using a nitrocefin hydrolysis spot-
test. 64 β-lactam-resistant isolates tested colourimetrically positive for β-lactamase activity 
(63%), with 38 isolates failing to hydrolyse nitrocefin (37%). Thereafter, the specific β-
lactamase activity using nitrocefin was determined for 10 E. coli isolates (from herbivore and 
pig faeces) displaying a variety of phenotypic β-lactam resistance profiles and nitrocefin 
hydrolysis reactions. Two pet pig isolates that failed to hydrolyse nitrocefin presented specific 
activities of <1 nmol  min-1  mg-1, while three farm pig isolates containing the blaTEM gene 
had specific activities of between 81 and 168 nmol  min-1  mg-1 - the highest observed among 
all 10 isolates. The results obtained demonstrate the presence of the blaTEM gene in farm pigs 
in KwaZulu-Natal, South Africa. However, detection of E. coli containing the gene in wild or 
“pristine” environments was not observed. Furthermore, the data show that while genotypic 
methods may effectively determine the presence or absence of resistance genes, it is 









Since the pioneering discovery of the first β-lactam, penicillin-G, in the late 1920s, β-lactam 
antibiotics have found extensive use in both clinical and veterinary environments (Fleming 
1929; Henderson 1997; Guenther et al. 2011). Following the introduction of penicillin as an 
antibiotic agent available to the public in the early-1940s, the first cephalosporin antibiotic was 
approved for clinical use in 1964 (Greenwood 2008). The frequent and favoured use of these 
broad-spectrum antibiotics can be largely attributed to their safety as pharmaceutical agents, as 
serious side-effects are rare (Moellering et al. 1989; Drawz and Bonomo 2010). 
Although initially hailed as a “miracle drug”, resistance to penicillin by Staphylococcus aureus 
was observed already in 1940 (Abraham and Chain 1940), initially in hospitals before spread 
to the community occurred (Rammelkamp and Maxon 1942; Kirby 1944).  The increase in 
bacterial resistance as a result of widespread and often indiscriminate use of these antibiotics 
in turn causes a reduction or even elimination of the agents’ efficacy in treating infections 
(Essack 2001). Resistance is most commonly mediated by the inactivation of the antibiotic 
itself through β-lactamases, as well as by reduced cell membrane permeability through the loss 
or alteration of porins and alteration of the antibiotic target sites (i.e. the penicillin-binding 
proteins) (Nikaido 2000; Essack 2001; Poole 2004).  
β-lactamases are enzymes that hydrolyse the amide bond of the β-lactam ring, rendering the 
antibiotic ineffective (Birnbaum et al. 1985; Majiduddin et al. 2002). In Gram-negative 
bacteria, β-lactamases are located in the periplasmic space situated between the outer and 
cytoplasmic membranes, and may be plasmid or chromosomally encoded depending on the 
enzyme type and bacterial species (Livermore, 1986). The efficacy of this resistance 
mechanism is influenced both by the enzyme’s affinity for the β-lactam antibiotic as well as 
the quantity of enzyme produced (Neu 1986; Livermore 1995). There are currently more than 
400 characterized β-lactamases; including ESBLs, carbapenemases and cephamycinases 
(Guenther et al. 2011; Graham et al. 2016). 
With the escalation of antibiotic resistance, it has become essential to develop methods to 
efficiently and accurately detect and characterize resistances in bacteria isolated from human, 
animal and environmental sources. Phenotypic methods include the well-established classical 
disk-diffusion procedure where pre-established breakpoint tables are used to determine the 




Ferraro 2009). This method in particular is very cost-effective and flexible. A potential 
disadvantage is the lack of automation in the case of large numbers of samples and antibiotics. 
Alternatively, more sophisticated genotypic methods like PCR can be utilized to screen 
bacterial isolates for the presence of known resistance genes. While this method can screen for 
specific genes encoding β-lactamases, selecting from the large number of known β-lactam 
resistance genes may prove difficult for routine laboratories. Furthermore, the presence of 
silent or pseudogenes may lead to false-positive results (Sundsfjord et al. 2004). Other methods 
that exist for β-lactam resistance detection include chromogenic tests. Established is the 
iodometric test, where iodine is reduced as a result of benzylpenicillin hydrolysis. The 
subsequent yield of penicilloic acid decolourizes the starch-iodine complex (Livermore and 
Brown 2001). Nitrocefin is a chromogenic β-lactam substrate, characterized by its structural 
similarity to the cephalosporin antibiotics, routinely used in the qualitative and quantitative 
detection of β-lactamases (Livermore and Brown 2001). Upon hydrolysis, nitrocefin changes 
from yellow to red, making it an effective chromogenic substrate (O’Callaghan et al. 1972; 
McManus-Munoz and Crowder 1999). Nitrocefin can be applied qualitatively as a reagent in a 
visual spot-test, or quantitatively in enzyme assays (O’Callaghan et al. 1972; Livermore and 
Brown 2001). Although an expensive substrate, the nitrocefin hydrolysis method is considered 
more sensitive and reliable than the iodometric test (Livermore and Brown 2001). 
The aim of this study was therefore to confirm and supplement the phenotypic profiles of β-
lactam-resistant Escherichia coli from South African wild herbivores and farm and pet pigs 
(Chapter 2), using genotypic and enzymatic methods. All β-lactam-resistant E. coli isolates 
were screened for the presence of one specific β-lactamase gene: blaTEM. Additionally, all 
isolates were subjected to a qualitative nitrocefin spot-test to determine the presence of β-
lactamase activity. Finally, the specific β-lactamase activity was determined for ten selected E. 







Materials and methods 
Bacterial strains 
A total of 102 β-lactam-resistant Escherichia coli strains isolated from faecal matter of 
herbivores and pet and farm pigs, as described in Chapter 2 above, were used for the following 
experiments. All isolates were resistant to at least one or more of the following β-lactam 
antibiotics: ampicillin, amoxicillin-clavulanate, cefotaxime, ceftazidime and aztreonam. 
Bacterial cultivation 
Isolates utilized for PCR analysis were grown overnight in 20 ml of nutrient broth (Oxoid), at 
37C and 120 rpm. For preparation of cell-free crude extract, 10 selected bacterial strains were 
grown in 100 ml of nutrient broth in 500 ml Erlenmeyer flasks, at 37C and 120 rpm until an 
OD600 of ~ 2 was achieved. 
Crude extract preparation 
Cells were harvested by centrifugation at 10 000 x g for 10 minutes at 4C (Beckman Avanti 
J-26 XPI), washed twice in sodium-phosphate buffer (0.5 M, pH 7), and finally centrifuged 
again at 10 000 x g for ten minutes followed by re-suspension in 1 ml of the same buffer. To 
obtain the crude extract, cells were disrupted using an ultrasonic treatment with a maximum 
output of 7 W (VirTis Virsonic 60, Polychem), consisting of 15 seconds sonication per 1 ml 
aliquot, followed by a 30 second cooling break on ice. The procedure was repeated ten times 
per isolate with manual mixing between each sonication. Cell debris was removed by 
centrifugation at 10 000 x g for 10 minutes at 4C, followed by a final centrifugation at 40 000 
x g for 45 minutes at 4C. The clear and cell-free supernatant was collected and stored at 20C 
until required. 
Protein determination 
The protein content of the crude extracts was determined according to Spector (1978), using 






PCR screening for the blaTEM gene 
Cells were harvested by centrifugation at 13 500 x g for 5 min (Progen GenFuge 24D) and the 
pellets re-suspended in 100 µl sterile distilled water. DNA was extracted using a freeze-thaw 
technique (Gemmell and Schmidt 2012). The following primers (Inqaba, South Africa) were 
used as described by Ahmed et al. (2007): blaTEM-F (5’-ATAAAATTCTTGAAGACGAAA-
3’), blaTEM-R (5’- GACAGTTACCAATGCTTAATC-3’). The amplification reactions were 
performed in 25 l volumes with 1.5 l template DNA, 0.5 l of each primer (10 M), 12.5 l 
2x DreamTaq Green PCR Master Mix (Thermo Scientific) and nuclease free water (Kapa). The 
PCR cycling conditions involved (Labnet MultiGene II thermocycler): initial denaturation step 
at 94°C for 2 minutes; 25 cycles of 94°C for 30 seconds; annealing at 55°C; extension at 72°C 
for 1 minute and a final extension cycle at 72°C for 7 minutes. PCR products were analysed by 
electrophoresis on 1% (w/v) agarose gel using a ready-to-use 1kb DNA ladder 
(ThermoScientific) as a size marker with addition of SYBR® Safe stain (Life technologies), 
and were visualized under UV light using a Gbox Chemi XRQ system (Syngene) and 
GeneSnap software. As negative controls, E. coli ATCC 8739 and water were used. The 
expected size of the blaTEM amplicon was 1080 bp. 
Nitrocefin spot-test 
One loop of colony biomass from each isolate grown on nutrient agar (Oxoid) at 37°C 
overnight was transferred to a well of a microtitre plate containing 20 l of a 0.5 mg/ml 
nitrocefin (Oxoid). The plate was manually agitated by gently rotating it on the work surface 
for one minute and then incubated in the dark at 30°C for 30 minutes. Development of a distinct 
red colour within 30 minutes constituted a positive result for nitrocefin hydrolysis. Heat 
inactivated E. coli ATCC 8739 cells and S. Typhimurium ATCC 14028 served as negative 
controls in the spot-test. In addition, one E. coli isolate from each animal group presenting 
susceptibility to all β-lactam antibiotics was tested using nitrocefin as a negative control. 
β-lactamase activity 
Crude extracts of ten selected isolates with positive (8) and negative (2) nitrocefin spot-test 
results were used to spectrophotometrically determine the specific β-lactamase activity. The 
hydrolysis of 10 μg of nitrocefin (Oxoid) in a total volume of 1 ml in the presence of 10-100 




buffer (0.5 M, pH 7) as described by O’Callaghan et al. (1972). The specific β-lactamase 
activities were determined using a molar extinction coefficient of 17 420 M-1cm-1 for the 
nitrocefin hydrolysis product as suggested by McManus-Munoz and Crowder (1999). The 
specific activity was established as nanomols of nitrocefin hydrolysed per minute per milligram 
of protein.  
To confirm hydrolysis of the β-lactam ring by nitrocefin, β-lactamase activity was 
demonstrated by measuring the absorbance spectra over time in the presence of crude extract 
from a representative E. coli isolate from farm pig, FP5 (Shimadzu UV1800 
Spectrophotometer). In a total volume of 1 ml, analysis of 10 μg of nitrocefin incubated in the 
presence of 43 μg protein from farm pig isolate FP5, in 0.5 M sodium-phosphate buffer (pH 
7.0) at 30C occurred.   
Chemicals 
Unless otherwise stated, all chemicals were of the highest purity commercially available. The 





A total of 102 Escherichia coli faecal isolates from three herbivores and pet and farm pigs 
(Chapter 2) presenting phenotypic resistance to either ampicillin (AMP), amoxicillin-
clavulanic acid (AMC), ceftazidime (CAZ), aztreonam (ATM) or a combination thereof - 
[Table A1], were screened using PCR. Only three farm pig E. coli isolates (FP5, FP6 and FP29) 
tested positive for the blaTEM gene [Figure 1]. 
 
  
FIGURE 1. Representative 1% agarose gel image depicting results of PCR: amplified blaTEM gene 




1 - 1 kb Molecular Weight Marker; 2 - FP5 (farm pig); 3 - FP6 (farm pig); 4 - FP29 (farm pig) 
[5 - Empty] 
6 - E. coli ATCC 8739; 7 - Nuclease-free water 














All 102 E. coli isolates were qualitatively screened for β-lactamase activity by means of a 
nitrocefin spot-test, with representative results shown in Figure 2. Of 102 β-lactam-resistant 
isolates, 64 (63%) tested positive for β-lactamase activity in the nitrocefin spot-test, while 38 
tested negative (37%) [Table A1]. All 6 E. coli isolates presenting resistance to ampicillin 
hydrolysed nitrocefin [Table A1]. The 6 ampicillin resistant E. coli isolates (one each from 
zebra, wildebeest and domestic pig, and three from farm pig), were all resistant in combination 
with amoxicillin-clavulanic acid, and either ceftazidime or aztreonam. Of 102 isolates, 61 
(from both herbivores and pigs) were resistant to only amoxicillin-clavulanic acid with 38 of 
these 61 (62%) testing positive for β-lactamase. Among the 38 E. coli isolates resistant to only 
amoxicillin-clavulanic acid, 7 of 9 giraffe isolates (78%) and 18 of 20 wildebeest isolates (90%) 
were nitrocefin positive. Conversely, only 3 of 7 zebra isolates (43%), 9 of 18 pet pig isolates 
(50%) and 1 of 7 farm pig isolates (14%) tested positive for nitrocefin hydrolysis. Phenotypic 
resistance to just one cephalosporin antibiotic, ceftazidime, occurred in 5 of 102 E. coli isolates, 
of which 3 (from zebra and giraffe faeces) were nitrocefin positive, while 2 isolates from pet 






















FIGURE 2. Nitrocefin spot-test for 8 randomly selected representative Escherichia coli isolates 
and two controls. The test was performed in a microtitre plate as indicated in the materials and 
methods section. 
Red indicates a positive reaction; Yellow indicates a negative reaction 
A1: FP5; B1: FP6; C1: FP29 (farm pig) 
A2: DP6; B2: DP5; C2: DP7 (pet pig) 
A4: Z2; (zebra) B4: W9 (wildebeest) 




Ten selected E. coli isolates displaying a variety of phenotypic resistance profiles and nitrocefin 
hydrolysis results were then further evaluated for specific β-lactamase activity [Table 1]. The 
E. coli isolates chosen represented herbivore, farm pig and pet pig isolates. Out of these 10 
isolates, 8 tested positive and 2 tested negative in the nitrocefin spot-test. The specific β-
lactamase activity was determined for all 10 isolates. For the nitrocefin-negative isolates (DP5 
and DP7 - pet pig isolates), the specific activity was <1 nmol  min-1  mg-1 [Table 1]. Isolates 
containing the blaTEM gene (FP5, FP6 and FP29 - farm pig isolates) showed specific activities 
of 144, 81 and 168 nmol  min-1  mg-1 respectively - the highest specific β-lactamase activity 
of all 10 isolates. The tested herbivore isolates Z2 and Z19 (zebra); W9 and W26 (wildebeest) 





TABLE 1. Nitrocefin spot-test results, blaTEM gene detection and specific β-lactamase 
activity (nmol  min-1  mg-1) for ten selected Escherichia coli isolates isolated from 
zebra, giraffe, wildebeest, pet pig and farm pig faeces in KwaZulu-Natal, South Africa. 
 
Isolate Nitrocefin spot-test result a blaTEM gene 
b 
Specific activity  
(nmol  min-1  mg-1) c 
FP5 + + 144 
FP6 + + 81 
FP29 + + 168 
Z2 + - 2 
Z19 + - 2 
W9 + - 3 
W26 + - 2 
G23 + - 2 
DP5 - - <1 
DP7 - - <1 
a + denotes a change in colour in the nitrocefin spot-test from yellow to red within 30 minutes 
incubation at 30C in the dark 
b + denotes the expected amplification product (1080 bp) for the blaTEM gene was obtained 






The hydrolysis of nitrocefin by β-lactamase activity was confirmed by UV-Vis spectrometry. 
[Figure 3]. The absorbance maximum due to the presence of nitrocefin at 390 nm decreased 
over time, and a new maximum, due to the hydrolytic cleavage of the β-lactam ring by 

















FIGURE 3. UV-Vis overlay spectra of a β-lactamase assay containing in a total volume of 1 ml; 
43 μg of protein from farm pig Escherichia coli isolate FP5 and 10 μg of nitrocefin in 0.5 M sodium-
















β-lactamases have been identified as one of the most important mechanisms of resistance to β-
lactam antibiotics, including penicillins, cephalosporins and monobactams, in bacteria 
including Escherichia coli, Klebsiella spp. and other Enterobacteriaceae (Bush 2001; Mesa et 
al. 2006; Bush and Jacoby 2010; Guenther et al. 2011). The genes encoding such enzymes can 
be found on both chromosomes and plasmids, the latter with the ability to be readily transferred 
between different bacteria (Bradford et al. 1994). The TEM-1 β-lactamase has been termed as 
the progenitor of the majority of extended spectrum β-lactamases, and genes encoding TEM-1 
are ubiquitous determinants of β-lactam resistance among bacterial isolates from diverse 
environments; including soil and water bodies, animal/agricultural communities and the clinic 
(Roy et al. 1992; Briñas et al. 2002; Guenther et al. 2011). The TEM-type β-lactamases were 
frequently found in E. coli isolated from the faeces of livestock including cattle and pigs in a 
number of countries including South Korea, Switzerland and China (Rayamajhi et al. 2008; 
Geser et al. 2012; Dahms et al. 2015; Gao et al. 2015). In this study, three E. coli isolates from 
farm pig faeces contained the blaTEM gene (FP5, FP6 and FP29) [Figure 1, Table A1]. Given 
the rather relaxed guidelines and laws regarding the use and prescription of antibiotics in farm 
environments in South Africa, the presence of such TEM-type resistance genes in E. coli from 
farm environments is therefore not unexpected (Eagar et al. 2012). Considering the poor 
representation of the African region in the 2014 WHO global surveillance report (WHO 2014), 
there may be an abundance of resistances due to β-lactamase genes in South African farm 
environments that are not identified or reported, potentially due to lack of infrastructure, 
personnel and efficient monitoring. A 2008 African study reported the presence of such β-
lactamase genes in E. coli isolated from farm pig faeces in Nigeria but did not specify the types 
and proportions of each β-lactamase gene found (Akujobi et al. 2008). In addition, genes 
encoding both the TEM-1 and TEM-20 type enzymes have been previously detected in E. coli 
strains isolated from cattle meat in Tunisia (Slama et al. 2010).  
According to the current literature, there has been no incidence of the blaTEM gene found in E. 
coli isolated from South African wild herbivores. However, the detection of this gene has been 
reported for wild birds (for example seagulls) and animals including wild rabbits and wild 
boars; on continents other than Africa (Literak et al. 2010; Radhouani et al. 2009; Silva et al. 
2010). The three isolates containing the blaTEM gene in the current study were all resistant to 




comprising three of the six ampicillin-resistant isolates in total [Table A1]. Such genes have 
been previously associated with E. coli isolates resistant to ampicillin in particular. Briñas et 
al. (2002) found that where 83% of ampicillin-resistant E. coli isolated from humans and 
healthy animals in Spain contained a TEM-type β-lactamase. Furthermore, Gonçalves et al. 
(2013) detected the blaTEM gene in ampicillin-resistant E. coli isolates from an Iberian lynx in 
Spain. In a study by Kaye et al. (2004), 52% of amoxicillin-clavulanic acid-resistant E. coli 
isolated from human urine contained the blaTEM gene, and the resistance observed was 
attributed to TEM type β-lactamase hyperproduction frequently observed as a mechanism of 
resistance to β-lactam/β-lactamase inhibitor combinations (Henquell et al. 1994; Nicolas-
Chanoine 1997; Kaye et al. 2004). Furthermore, these isolates displayed rapid hydrolysis of 
nitrocefin, suggesting that TEM gene hyperproduction plays an important part in mediating 
amoxicillin-clavulanic acid resistance (Kaye et al. 2004). 
The fact that the blaTEM gene was not detected in any herbivore E. coli isolate in the current 
study may be explained by the environment from which the isolates were obtained. Given the 
apparently more “exotic” habitat, the genes that could be conferring resistance against β-lactam 
antibiotics may not be among those resistance genes that are typically tested in wild animal-
based settings. Moreover, it may be an indication that resistance mechanisms other than β-
lactamase encoding genes are involved in conferring the observed β-lactam resistance, for 
example porins. 
The chromogenic cephalosporin nitrocefin [Figure 4] is a well-established substrate used in the 
colourimetric assessment of β-lactamase activity in bacterial isolates, including E. coli 
(O’Callaghan et al. 1972; Livermore and Brown 2001). β-lactamase enzymes can catalyse the 









In the nitrocefin spot-test [Figure 2], 63% (64/102) of E. coli isolates tested positive for the 
presence of β-lactamase activity, with 38 of these 64 isolates resistant to only amoxicillin-
clavulanic acid. Wildebeest-faecal isolates constituted a large proportion thereof (18 
amoxicillin-clavulanic acid resistant and nitrocefin positive isolates), which might be related 
to the dietary habits of the animal - it is a grazer and would likely ingest soil particles while 
feeding, or perform geophagia. Moreover, given that clavulanic acid is produced by 
Streptomyces clavuligerus, a typical soil bacterium, the presence of resistances to such 
antibiotics is not unexpected (Higgens and Kastner 1971; Reading and Cole 1977). 
A number of E. coli isolates in this study presented phenotypic resistance to one or more β-
lactam antibiotic but when tested for nitrocefin hydrolysis presented a negative result [Figure 
2; Table A1]. This may be due to alternative mechanisms conferring resistance to β-lactam 
antibiotics, such as porins, or that nitrocefin is not an appropriate substrate for the β-lactamase 
(or β-lactamases) present. While an isolate may present phenotypic resistance to one or more 
β-lactam antibiotics, a negative result for nitrocefin hydrolysis does not automatically eliminate 
the possibility that β-lactamases may be the mechanism conferring resistance. This was 
illustrated in a study conducted by Miriagou et al. (2003), where the Class B metallo-β-
lactamase VIM-1 was undetectable in E. coli when nitrocefin was employed as a substrate. 
Similarly, Villadares et al. (1996) utilized nitrocefin as a substrate for a variety of β-lactamases 
including CphA (a Class B β-lactamase) from Aeromonas hydrophila. The resultant kinetic 
parameters of the CphA enzyme were determined, and a very low kcat/Km value of 0.0003 μM-
1s-1 was obtained (Villadares et al. 1996), suggesting that nitrocefin was not effectively 
hydrolysed in the reaction. The same enzyme (CphA) was analysed using an alternative 
chromogenic substrate, CENTA, and again no detectable hydrolysis was observed (Bebrone et 
al. 2001). Two additional studies analysed the hydrolysis of nitrocefin by Class A β-lactamases 
TEM-1 and SHV-1 in E. coli. The catalytic efficacy differed by a factor of 20 between the β-
lactamases, with TEM-1 measuring 18 μM-1s-1 and SHV 0.84 μM-1s-1 (Raquet et al. 1994; 
Bouillenne et al. 2000). These results confirm that certain β-lactamases may be present in an 
isolate, but are unable to efficiently hydrolyse nitrocefin and other chromogenic 
cephalosporins.  
Nitrocefin [Figure 4] was chosen as the substrate for both the spot-test and β-lactamase activity 
quantification in this study, due to the distinctive colouration of the hydrolysed (red) and 




determination of isolates’ β-lactamase activity profiles. In the current study, the specific β-
lactamase activity of the nitrocefin-positive representative herbivore E. coli isolates (Z2, Z19, 
W9, W26 and G23 - zebra, giraffe and wildebeest faecal isolates) were between 2 and 3 nmol 
 min-1  mg-1 [Table 1]. In contrast, the specific β-lactamase activities of the nitrocefin-
positive representative farm pig E. coli isolates - FP5, FP6 and FP29 - were much higher, at 81 
to 168 nmol  min-1  mg-1 [Table 1]. In a study assessing the β-lactamase activity of a TEM-
producing clinical E. coli strain, the measured specific activity was 320 nmol  min-1  mg-1 
(Payne et al. 1994). The highest specific β-lactamase activities were detected in the presence 
of a TEM β-lactamase gene in the current study, as the three farm pig E. coli isolates (the only 
3 of 102 to carry the blaTEM gene) presented high specific β-lactamase activities.  Händel et al. 
(2013) determined the specific activities of both amoxicillin-susceptible and amoxicillin-
resistant E. coli cells, and reported that the amoxicillin-resistant cells had much higher specific 
activities - in this case attributed to strong upregulation of the ampC gene (Händel et al. 2013). 
The results obtained might infer that the expression of a TEM gene results in a greater measured 
specific β-lactamase activity, or that in fact the TEM resistance determinant is integral in 
conferring higher levels of β-lactamase activity among E. coli strains. The lower specific β-
lactamase activities of the herbivore isolates may be explained by low expression, the presence 
of rare β-lactamases that are not readily hydrolysing nitrocefin - or in the case of nitrocefin-
negative isolates - resistance is not conferred by β-lactamases but rather alternative 
mechanisms. 
The results of the nitrocefin spot-test in this study demonstrated that nitrocefin can be an 
effective substrate for testing β-lactamase activity. However, it may miss certain β-lactamases 
in phenotypic screening, as observed when the phenotypic β-lactam resistance profiles did not 
always correlate with the spot-test results. It is therefore advisable when screening for potential 
β-lactam resistance to use multiple methods when testing for the presence of β-lactamases, 
particularly in lesser-known “wild” environments. There might be application of a phenotypic 
assessment using the disk diffusion test or the MIC method, the genotypic target of β-lactamase 
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General conclusions and future research potential 
The issue of antibiotic resistance is not confined to humans and the clinic, but is in fact 
persistent in a large number of ecological niches; from the general surrounding environment 
(soil, water and vegetation), to animals inhabiting wild and domestic habitats. While the burden 
of antibiotic resistance has been well-characterized in both clinical and farm environments 
worldwide, it has recently emerged that animals inhabiting an apparently “pristine” 
environment, for example wild herbivores in nature reserves, may serve as reservoirs and/or 
vectors of antibiotic resistant bacteria. Such data is however particularly limited for South 
African herbivores.  
Thus, this thesis aimed to screen Escherichia coli isolated from the faecal matter of different 
herbivores residing in a nature reserve in KwaZulu-Natal, South Africa; to assess the current 
status of local wild animals as potential reservoirs or vectors for antibiotic resistant bacteria. In 
addition, Escherichia coli from both pet (companion) and farm pig faeces was evaluated for 
comparative purposes. 
The data established in this thesis show that South African wild herbivores do indeed serve as 
reservoirs and thus potential vectors of antibiotic resistant E. coli. Furthermore, the results 
obtained indicate that the feeding habits of the animals - whether they browse for food at the 
tops of trees (e.g. giraffes), or graze at ground-level (e.g. zebra and wildebeest) - apparently 
influence the observed antibiotic resistance profiles. This was evident from the significantly 
higher levels of antibiotic resistance observed for E. coli isolates from zebra and wildebeest 
faeces (grazers), when compared to resistance levels observed for isolates from giraffe faeces 
(browser). This may be due to geophagy, leading to uptake of secondary metabolites including 
antibiotics produced by soil microorganisms (Mahaney et al. 1999). An additional reason might 
be selective pressure imposed by the potential application of herbicides to ground-level shrubs 
and grasslands, where induction of antibiotic resistant phenotypes in bacterial pathogens can 
occur (Kurenbach et al. 2015). The usage of such agents in Bisley Park or the surrounding area 
is however unconfirmed. 
The lack of resistance to carbapenem, fluoroquinolone or glycylcycline antibiotics in any of 
the wild herbivore E. coli isolates was not entirely unexpected, as such antibiotics are reserved 




Considering the potential resistances that might exist faecal bacteria from horses in the adjacent 
stables, or companion animals entering the park - both of which may arise as a result of 
presumed veterinary attention - it is encouraging that such resistances have not yet been 
observed in E. coli isolated from the wild animals. There was no incidence of multidrug 
resistance (MDR - resistance to at least one antibiotic from at least three different classes) 
among those faecal E. coli isolates from giraffe or wildebeest faeces. However, a remarkably 
large proportion of E. coli from zebra (47%) presented a MDR phenotype. Although generally 
unanticipated, a high incidence of MDR from wild animals in Africa is not unheard of: two 
separate studies performed in Botswana screened faecal E. coli from a number of animals 
including banded mongoose, giraffe, otters, spotted hyena and impala; and reported instances 
of MDR E. coli isolates. In some cases, a 100% MDR rate was even observed, as for E. coli 
from otter and hyena faeces (Pesapane et al. 2013; Jobbins and Alexander 2015). The results 
from these studies were largely attributed to the animal’s dietary habits (herbivore or 
omnivore), proximity to urban areas and frequency of water association. It might be important 
for future studies to screen the same herbivores (zebra, giraffe, wildebeest), but from diverse 
habitats - for example game reserves in different locations or grasslands around the country. 
Similarly, an investigation into different South African herbivores, but with identical dietary 
habits to the current herbivores (i.e. browser or grazer) might be enlightening. Such results 
would verify whether the findings from this study are confined to the Bisley Park Nature 
Reserve (KZN) and its inhabitants, or are indeed due to the dietary behaviour and feeding habits 
of the animals.  
While herbivores and pet pigs presented similar resistance profiles in certain cases (more than 
80% of E. coli isolates from each zebra, wildebeest and pet pig faeces presented resistance to 
at least one antibiotic), there was a significant difference between farm and pet pig with regard 
to amoxicillin-clavulanate resistance. One farm pig E. coli isolate (out of 30) presented 
resistance to the two tested fluoroquinolone antibiotics, ciprofloxacin and norfloxacin - not 
entirely unexpected considering the extensive use of fluoroquinolones in farm environments 
(Collignon 2005). E. coli isolated from pet pig faeces had the second highest rate of MDR, with 
10% of isolates presenting such a phenotype. This is not surprising considering the 
“companion” nature of the pet pig; a lifestyle which includes regular veterinary attention and 





To supplement the disk diffusion methodology, additional PCR-based screening for one 
selected resistance gene was performed, as well as screening for the β-lactamase activity of β-
lactam-resistant E. coli isolates. Upon analysis, only three farm pig E. coli isolates were found 
to carry the blaTEM gene. Considering the largely clinical nature of this particular gene, it is 
probably unsurprising that it was not detected in the “exotic” wild herbivore E. coli isolates. 
Upon investigation into β-lactamase activity, approximately 63% (64 out of 102 β-lactam-
resistant isolates) tested positive for nitrocefin hydrolysis. Such isolates were from both 
herbivore and farm and pet pig faeces. All isolates testing positive for the blaTEM gene (3 E. 
coli isolates from farm pig faeces) exhibited phenotypic resistance to ampicillin, amoxicillin-
clavulanic acid and ceftazidime. A number of phenotypically β-lactam-resistant isolates, when 
screened using nitrocefin, failed to hydrolyse this substrate. This may be attributed to one of 
two things: β-lactam resistance is conferred by a mechanism other than a β-lactamase, such as 
a porin or an efflux pump. Alternatively, there may be a β-lactamase that does not hydrolyse 
nitrocefin, as is the case for certain Class B enzymes including VIM-1 (Miriagou et al. 2003). 
This highlights that PCR-based approaches for resistance profiling may not be sufficient when 
applied in isolation. Phenotypic methods such as the disk-diffusion assay and/or enzyme assays 
are essential to supplement the results. It might be practical to consider characterization of the 
types of β-lactamase enzymes present in those isolates testing positive for β-lactamase activity, 
through the selection of a greater number of appropriate β-lactamase genes. In contrast, for 
isolates that presented a negative nitrocefin hydrolysis result, it will be of interest to 
characterize the resistance mechanism conferring β-lactam resistance - be it a β-lactamase 
unable to hydrolyse nitrocefin, or another mechanism such as porins. The use of additional 
colourimetric substrates, for example the iodometric test or CENTA, could further verify the 
screening results from nitrocefin testing (Bebrone et al. 2001; Livermore and Brown 2001). 
Ten isolates with distinct phenotypic resistance profiles and varied responses to the nitrocefin 
hydrolysis test were selected for determination of specific β-lactamase activity. The results 
indicated that the presence of the blaTEM gene was linked to high levels of specific nitrocefin 
hydrolysis activity in isolates containing the gene, as these activities were at least 20 times 
higher than those in nitrocefin positive isolates lacking the blaTEM gene. While crude extracts 
from herbivore-sourced E. coli isolates (2 from zebra, 2 from wildebeest and 1 from giraffe 




isolates from farm pigs with the blaTEM gene had specific activities ranging from 81 to 168 
nmol  min-1  mg-1.  
Additional research that could be performed to supplement the results described in this thesis 
may include the screening of E. coli isolated from faecal samples from the horses inhabiting 
the stables adjacent to Bisley Park Nature Reserve. Such an assessment may provide insight 
into whether matching resistance profiles occur between E. coli from the horses that can enter 
the park, and E. coli isolated from the herbivores. Furthermore, the isolation of E. coli and 
subsequent determination of antibiotic resistance profiles from the proximate soil and water-
bodies in the park might reveal similarities to those obtained from the herbivores. Antibiotic 
resistance transmission relies on the interconnection of a number of biotic and abiotic factors; 
thus the additional screening would provide a necessary insight into the function of such 
factors. 
A limitation of this study is that potential seasonal influences were not assessed. The samples 
analysed in the study were collected between March and April 2015 - the late summer/early 
autumn season in South Africa, while samples were not collected during the winter season. 
There may be a change in behaviour of the animals in the dry colder months - grazing may 
perhaps be less frequent, and there might also be an element of migratory birds (capable of 
transferring resistances via faeces) present in one season but not the next. If geophagy is indeed 
a potential explanation for the detection of resistance in E. coli isolated from wild herbivores, 
one might find that the colder temperatures influence the activity of streptomycetes present in 
the soil thus potentially impacting the antibiotic resistances detected in winter. 
In conclusion, wild herbivores in South Africa indeed serve as reservoirs of antibiotic resistant 
E. coli, and thus may function as a vector for the transfer of resistance to other animals or even 
humans. Furthermore, farm pigs may contain bacteria resistant to important antibiotics from 
antibiotic classes including the fluoroquinolones and third-generation cephalosporins; as well 
as potentially harbour antibiotic resistance genes including blaTEM. Considering the knowledge 
gap with regard to antibiotic resistance in South African wild animals, this research has 
provided a first insight into the role such animals may play in their environment as a reservoir 
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APPENDIX TABLE A1. Resistant, susceptible, and intermediate phenotypes for Escherichia coli isolated from zebra, wildebeest, 
giraffe, pet pig and farm pig faeces; including presence or absence of the blaTEM gene and nitrocefin spot-test results as described in 
Chapter 1 and 2 above. 
 
  ANTIBIOTIC   














Z1 S R S R S I I S S I I S - + 
Z2 S R S R I I I S S I R S - + 
Z3 S R S R I I I S S I R S - - 
Z4 S R S R I S S S S I R S - + 
Z5 S R S R I I S S S I R S - - 
Z6 S R S R I I I S S I R S - - 
Z7 S R S R S I S S S I R S - + 
Z8 S R S R I S S S S I R S - - 
Z9 R R S R I S S S S I I S - + 
Z10 S R S I I I S S S I R S - - 
Z11 S R S I R S S S S I R S - + 
Z12 S R S I I S S S S I R S - + 
Z13 S R S I I S S S S I I S - - 
Z14 S R I R R S S S S I I S - - 
Z15 S R S R I S S S S I I S - + 
Z16 S S I I I S S S S I I S NT - 
Z17 S R I I R S S S S I R S - + 
Z18 S R I R I I S S S R I S - + 
Z19 S S I R R I S S S I R S - + 
Z20 S R I R R S S I I I R S - - 
Z21 S S I I I I S S S I R S NT NT 






Z23 S S S R I I S I I I R S - + 
Z24 S R S R I I I I I I R S - - 
Z25 S S I I I I S I I I R S NT NT 
Z26 S R S I S S I S S I I S - + 
Z27 S R I I I S S I S I I S - - 
Z28 S R S I I S S S S I I S - - 
Z29 S R S I I S S S S I I S - + 












G1 S S S I I S S S S I I S NT - 
G2 S R S I I S S S S I I S - + 
G3 S S S I I I S S S I I S NT NT 
G4 S R S I I S S S S I I S - + 
G5 S S S I S S S S S S S S NT NT 
G6 S S S S S S S S S S I S NT NT 
G7 S S S S S S S S S S I S NT NT 
G8 S S S S S S S S S S S S NT NT 
G9 S S S I S S S S S I I S NT NT 
G10 S S S I S S S S S S I S NT NT 
G11 S S S S S S S S S I I S NT NT 
G12 S S S I S S S S S S S S NT NT 
G13 S S S S I S S S S I R S NT NT 
G14 S S S I I S S S S S I S NT NT 
G15 S R S I S S S S S S I S - + 
G16 S S S I I S S S S I I S NT NT 
G17 S R I I S S S S S I R S - + 
G18 S S S I I S S S S I I S NT NT 
G19 S S S S S S S S S I I S NT NT 






G21 S R S I S S S S S I R S - + 
G22 S S S I I S S S S I I S NT NT 
G23 S S S R S S S S S I I S - + 
G24 S S S I S S S S S I I S NT NT 
G25 S R S R S S S S S I I S - - 
G26 S S S I I S S S S I I S NT NT 
G27 S R S I I S S S S I I S - + 
G28 S R S I I S S S S I I S - - 
G29 S R S I S S S S S I I S - - 















W1 S R I I I I S S S I R S - + 
W2 S R S I I I S S S I I S - + 
W3 S R S I I I S S S I I S - + 
W4 S R S I I S S I S I I S - + 
W5 S S I I I I S S S I I S NT - 
W6 S R S I I S S S S I I S - - 
W7 S R S R I S S I S I I S - + 
W8 S R S I I I S S S I I S - + 
W9 R R I I I I S S S I I S - + 
W10 S R S I I S S S S I I S - + 
W11 S S S I S S S S S I I S NT NT 
W12 S S S I S S S S S I I S NT NT 
W13 S R S I I S S S S I I S - + 
W14 S R S I I S S S S I I S - + 
W15 S R S I S S S S S I I S - + 
W16 S R S I S S S S S I I S - + 
W17 S R S I I I S S S I I S - + 






W19 S R S I S S S S S I I S - + 
W20 S R S I S S S S S I I S - - 
W21 S R I I I I S S S I I S - + 
W22 S R S R I S S S S I I S - + 
W23 S S I I I S S S S I I S NT NT 
W24 S S S I I S S S S I I S NT NT 
W25 S R S I I S S S S I I S - + 
W26 S R S I R I S S S I I I - + 
W27 S R S I I S S S S I I S - + 
W28 S R S I I S S S S I I S - + 
W29 S R S I I S S S S I I S - + 










DP1 S R S S S S S S S I I S - + 
DP2 S R S I I S S S S I I S - + 
DP3 S R S I S S S S S S I S - + 
DP4 S R I I I S S S S I R S - + 
DP5 S S I R I I S S S I I S - - 
DP6 R R I R I S S S S I I S - + 
DP7 S R S R I S S S S I R S - - 
DP8 S S S I I S S S S I I S NT - 
DP9 S R I I I S S S S I R S - - 
DP10 S R I I I S S S S I I S - - 
DP11 S R I R I S S S S I I S - + 
DP12 S R S I I S S S S I R S - - 
DP13 S R S S I S S S S I I S - - 
DP14 S R I R I S S S S I R S - - 
DP15 S R S I S S S S S I I S - - 






DP17 S S S R I S S S S I I S - - 
DP18 S R S I S S S S S I I S - + 
DP19 S R I R I S S S S I I S - + 
DP20 S R S I S S S S S I R S - + 
DP21 S R S I S S S S S I I S - - 
DP22 S R I I I S S S S I I S - + 
DP23 S S S R R S S S S S I S - - 
DP24 S R S R I S S S S I R S - + 
DP25 S S S I S S S S S I I S NT NT 
DP26 S R S I I S S S S I I S - - 
DP27 S R S I S S S S S I I S - - 
DP28 S S S I I I S S S I I S NT NT 
DP29 S R S I I S S S S I I S - + 












FP1 S S S I S S S S S I I S NT - 
FP2 S S S I I S S S S I I S NT NT 
FP3 S S S I S S S S S I I S NT NT 
FP4 S S S I I S S S S I I S NT NT 
FP5 R R S R I S S S S I I S + + 
FP6 R R I R I S S S S R I S + + 
FP7 S S S I I I S S S I I S NT NT 
FP8 S R S I I S S S S I I S - - 
FP9 S S S I S S S S S S S S NT NT 
FP10 S S S I I S S S S I I S NT NT 
FP11 S S S I S S S S S I I S NT NT 
FP12 S S S S I I S S S I I S NT NT 
FP13 S S S S I S S S S I I S NT NT 






FP15 S R S I I S S S S I I S - - 
FP16 S S S I I S S S S I I S NT NT 
FP17 S S S I I S S S S I I S NT NT 
FP18 S S S I I S S S S I I S NT NT 
FP19 S R S I S S S S S I I S - - 
FP20 S S S I I S S S S I I S NT NT 
FP21 S R I I I S S S S I I S - - 
FP22 S R I R I S S S S I I S - - 
FP23 S S I I I I S S S I I S NT NT 
FP24 S R S I I I S S S I I S - - 
FP25 S S S S S S S S S I I S NT NT 
FP26 S S I I R S S S S I R S - - 
FP27 S R S R I S S I I I I S - + 
FP28 S R S I I S S S S I I S - + 
FP29 R R S I R S S R R I I S + + 
FP30 S R S R I S S S I I I S - + 
 
a + denotes the expected amplification product (1080 bp) for the blaTEM gene was obtained 
b + denotes a change in colour of the nitrocefin/biomass mixture from yellow to red after 30 minutes incubation at 30C in the dark 
NT Not tested 
Note: one isolate from each animal group presenting susceptibility to all β-lactam antibiotics was tested using nitrocefin as a negatiative control: 


















APPENDIX FIGURE A1. Representative 1% agarose gel image depicting results of PCR based 
amplification of the gadA gene (680 bp), from farm pig Escherichia coli.  E. coli ATCC 8739 
served as a positive control and sterile nuclease free water as a no template control 
 
1 - 100 bp Molecular Weight Marker; 2-4 - FP1-3 (farm pig); 5 - E. coli ATCC 8739;  
6 - Nuclease free water 
1       2     3      4       5       6 
